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Abstract
Primary open-angle glaucoma is the most common form of glaucoma and the secondleading cause of preventable blindness worldwide. Although timely diagnosis and proper
adherence to therapeutic regimen prevent blindness, patient nonadherence continues to be
the greatest challenge to effective treatment. Preliminary research suggested that culturally
interactive education delivery may increase patient adherence. However, this education
intervention had not occurred with glaucoma treatment. The transtheoretical model of
behavior change served as the framework for this study. The research questions addressed
the effect that glaucoma education provided by a culturally competent patient navigator had
on patient knowledge of glaucoma, adherence to medication use, and follow-up
appointment attendance. This quantitative study had a longitudinal design with archival
data from 206 Russian Eastern European immigrant patients. The control group had a
standard appointment with an ophthalmologist, and the experimental group had an
interactive educational experience with a patient navigator after the standard appointment.
The navigator administered the Glaucoma Knowledge Index at three time points: before the
appointment (T1), after the appointment (T2), and at a 1-month follow-up (T3). The
intervention group showed a statistically significant increase in glaucoma knowledge
retention at T2 and T3. However, this increase in knowledge did not correspond to a
statistically significant difference in patients’ adherence to follow-up eye exam attendance
or ocular medication adherence. The outcome of this study may form the basis for
discussions among policymakers leading to positive social change.
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Chapter 1: Introduction to the Study
Glaucoma causes progressive damage to the optic nerve and is the leading cause
of irreversible blindness worldwide (Abdull et al., 2016). Blindness from glaucoma is
avoidable with early diagnosis and appropriate, sustained life-long treatment (Abdull et
al., 2016; Kyari et al., 2016). With adequate knowledge, adherence to follow-up care, and
proper ocular medication utilization, patients can prevent blindness from this disease.
However, many patients fail to adhere to treatment recommendations and lose most of
their vision (Nowak & Smigielski, 2015).
Poor outcomes in patients with glaucoma often stem from barriers to care, such as
difficulty traveling to appointments, poor access to eye care, the prohibitive cost of eye
exams and treatment, and ocular medication noncompliance (Davis et al., 2018; Johnson
et al., 2016; C. X. Zheng et al., 2016). Another significant reason for nonadherence to
treatment is a lack of understanding of the glaucoma diagnosis and its severity, especially
when the patient is asymptomatic (Nowak & Smigielski, 2015; van Zyl et al., 2015; C. X.
Zheng et al., 2016). The absence of symptoms in almost all glaucoma patients can
increase the risk of treatment nonadherence (De-Gaulle & Dako-Gyeke, 2016).
Nonadherence to ocular medication and follow-up medical care leads to irreversible
vision loss, preventable falls and injuries, decreased quality of life, social isolation, and
depression (Tan et al., 2018; D. D. Zheng et al., 2018).
Chapter 1 presents a discussion of the background of the research and the problem
statement as well as the purpose of the study, research questions, and hypotheses. I
provide the theoretical framework, the nature of the study, definitions, assumptions,
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scope, delimitations, and limitations. The chapter concludes with the significance of the
study and a summary.
Background
Glaucoma is a chronic optic neuropathy resulting in visual field defects,
progressive vision loss, and blindness (Zhang et al., 2015). Glaucoma is the secondleading cause of irreversible blindness in the United States, with New York State reported
to have one of the highest rates of glaucoma (National Academies of Sciences,
Engineering, and Medicine, 2016; Prum et al., 2016). Given the rapidly aging U.S.
population, the National Academies of Sciences, Engineering, and Medicine (2016)
predicted that glaucoma would increase by 50% to 3.36 million people in 2020. The
estimated annual U.S. health care costs associated with glaucoma are $2.9 billion, with
the increasing prevalence of glaucoma expected to cause a significant economic and
quality-of-life burden (Callinan et al., 2017). The prevalence of this disease varies greatly
across ethnic and racial groups (Gupta et al., 2016; Hark et al., 2017; Komolafe et al.,
2013; Nowak & Smigielski, 2015; Prum et al., 2016).
Primary open-angle glaucoma (POAG) is the most common form, affecting 2.2 to
2.7 million Americans (Mahabadi et al., 2019). Asymptomatic until the optic nerve
damage is severe, POAG develops slowly and is associated with poor drainage of the
aqueous humor, leading to elevation of intraocular pressure and subsequent damage to
the optic nerve ganglion cells (Dietze et al., 2019). The prevalence of POAG is often
higher in individuals of African descent, with minimal data available about POAG rates
among Eastern Europeans who have immigrated to the United States (Murdoch et al.,
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2020; Nowak & Smigielski, 2015). However, in 2010, POAG was highest among Eastern
European immigrant populations and represented 23.9% of those with POAG worldwide
(Centers for Disease Control and Prevention [CDC], 2015; Nowak & Smigielski, 2015;
Quigley & Broman, 2006).
Patient nonadherence to physicians’ prescribed therapeutic regimen is the greatest
challenge to treating patients with glaucoma effectively (Varma et al., 2016). Several
barriers contribute to patient nonadherence to glaucoma treatment and follow-up care.
Patients with glaucoma have reported difficulty finding transportation to eye care
appointments without access to a car, someone to accompany them, and the social
support needed to comply with follow-up care (Ibrahim et al., 2015; C. X. Zheng et al.,
2016). Additionally, patients might lack education about their condition, experience
significant discomfort from ocular glaucoma medications, receive inadequate eye drop
instillation training, and deny the risk of blindness due to the asymptomatic nature of
glaucoma (Davis et al., 2018; Thompson et al., 2015; Varma et al., 2016).
Livne et al. (2017) demonstrated that patient education is an essential component
of the care provided by health care professionals. Educating patients about their chronic
conditions will lead to improved patient participation in self-care, increased quality of
life, and better psychological and physiological outcomes. Patient education also
contributes to decreased stress, anxiety, and costs associated with blindness and falls.
Livne et al. discovered that education influenced patients’ motivation to follow
recommendations, consequently improving treatment compliance. Despite these benefits,
patient teaching has received little attention as, after receiving a chronic glaucoma
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diagnosis, patients receive insufficient information about their illness and appropriate
care (Killeen et al., 2020; Livne et al., 2017).
Economic forces have driven a private-practice focus on productivity and
efficiency, with performance metrics pushing physicians to see higher volumes of
patients with less time for each (Rider et al., 2018). Additionally, frequent cuts in
managed care reimbursements force physicians to work faster to maintain their income,
decreasing the time spent in meaningful interactions and compromising the traditional
patient–doctor relationship (Rider et al., 2018). In the 1995 Commonwealth Fund Survey,
41% of physicians noted a decline in the amount of time spent with patients (Dugdale et
al., 1999).
Among patients complying with ocular medication treatment, inadequate
education about proper administration of glaucoma drops leads to ineffective medication
delivery and continuing eye damage (Davis et al., 2018). Unlike traditional medical
specialties, where the role of education belongs to nurse professionals, the field of
ophthalmology does not have a nursing specialty. Accordingly, there is a significant
patient education gap in ophthalmological health care delivery specific to glaucoma.
Despite efforts made to justify the role of ophthalmic nurses, there has been nothing done
to propel this specialty forward (Moradi, 2016).
In the 1990s, Freeman developed the concept of a patient navigator to reduce
barriers to breast cancer care in Harlem, New York (Freeman & Rodriguez, 2011). Since
then, primary care settings have adopted the approach, as a trained person (patient
navigator) engages with patients to educate them and improve health care access (Peart et
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al., 2018). Recently, patient navigator duties have extended to addressing barriers patients
have to care, such as providing education about their conditions and coordinating
appointments. These services are especially important for vulnerable populations who
find their access to care compromised by a range of geographic, demographic,
socioeconomic, or cultural characteristics (Peart et al., 2018). In a 1-year randomized,
controlled trial, Hark, Johnson, et al. (2016) evaluated the impact of a patient navigator
on glaucoma eye care follow-up adherence in an urban community setting versus an
office-based setting. The researchers found that help from a patient navigator did not
increase the likelihood of keeping follow-up appointments; however, the authors believed
this was due to inconsistent follow-up appointment schedule and patient self-selection.
Hark, Johnson, et al. did not analyze the value of patient navigators in educating patients
about glaucoma or ocular medication administration.
Research has indicated that half of glaucoma cases are undiagnosed, and this rate
is even higher among at-risk populations (Fudemberg, Amarasekera, et al., 2016).
Without appropriate treatment and routine long-term follow-up care, glaucoma can cause
irreversible vision loss (Hark et al., 2017). Patient nonadherence to glaucoma treatment
exacerbates the disease, leading to irreversible blindness (Hahn & Truman, 2015).
However, when patients and medical providers adhere to recommended standards of care,
the risk of blindness significantly declines (Hahn & Truman, 2015; Sleath et al., 2014).
Problem Statement
The asymptomatic nature of POAG means the disease frequently remains
undiagnosed until the advanced stages (Hark, Waisbroud, et al., 2016). Early diagnosis is
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critical to preventing blindness; by the time patients become symptomatic, severe and
irreversible damage has already occurred. Despite aggressive therapy, initiating available
treatment at late diagnostic stages cannot stop disease progression (Zhang et al., 2015).
POAG most affects individuals who are at risk for socioeconomic disadvantage and are
unable to schedule regular eye screenings due to their lack of knowledge, inability to
understand the diagnosis, and scarcity of financial means for copayments and travel
(Sapru et al., 2017). Certain ethnic groups, such as Russian Eastern Europeans, have a
genetic predisposition to developing POAG (Nowak & Smigielski, 2015).
Research evaluating education’s effectiveness in improving health-related
outcomes showed that education was a means to intentionally engage patients in self-care
while promoting health equality in at-risk populations (Hahn & Truman, 2015). The
provision of such education requires high-level patient–physician engagement (Hark,
Waisbroud, et al., 2016). However, due to the economic pressures on medical providers,
many physicians no longer have the resources for this time-consuming process (Rider et
al., 2018). The gap in research addressed by the current study pertained to the
effectiveness of education provided by the patient navigator in patients’ native language
on their knowledge and understanding of glaucoma, as well as their adherence to followup care and prescribed ocular medications. To reduce this gap, I analyzed archival data
from a private glaucoma clinic in New York.
Purpose of the Study
The purpose of this quantitative study was to examine the effect of education
about glaucoma through a patient navigator on patient knowledge of glaucoma and
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patient adherence to follow-up care. The process entailed examining a randomly split
convenience sample of 206 participants into two equal groups to compare whether
additional education in one group produced an effect on glaucoma knowledge, adherence
to ocular medication use, and follow-up appointment attendance. Group 1 was a control
group that received a standard exam; Group 2 received the standard exam and additional
education provided by a patient navigator. Participants were from the Russian Eastern
European immigrant population at a private glaucoma specialty clinic in New York.
Determining patients’ glaucoma knowledge entailed the administration of the Glaucoma
Knowledge Index (GKI) at three time points: before the exam (T1), immediately
following the exam in Group 1 and the exam and additional education in Group 2 (T2),
and at a 1-month follow-up appointment (T3). The goal of gathering data at T1 was to
measure patients’ baseline information about glaucoma. T2 served as a manipulation
check to determine whether the provided education was effective and whether there were
differences between Group 1 and Group 2 in knowledge comprehension and retention
after the appointment. Finally, data gathered at T3 showed whether participants had a
significant, persistent, meaningful change with a lasting effect for subsequent
recommendation to health care providers. Also evaluated at the 1-month follow-up
appointment was whether patients attended appointments and used their drops as
prescribed.
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Figure 1
Consort Diagram for the Study Design
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Figure 1 presents a detailed consort diagram for the study design. The study
outcome could be key to encouraging ophthalmological practices treating glaucoma
patients to hire and train culturally competent staff to fulfill the role of patient navigators.
Additionally, the findings could bring awareness to the growing need for patient
education among vulnerable, at-risk populations and encourage other researchers to
conduct more extensive studies in other specialties of ophthalmological patient care.
Research Questions and Hypotheses
This was a quantitative study with five research questions (RQs).
RQ1: Are there significant differences between pretest and posttest in knowledge
of glaucoma as a function of whether patients are provided with additional education?
H01: There are no significant differences between pretest and posttest in
knowledge of glaucoma.
Ha1: There are significant differences between pretest and posttest in knowledge
of glaucoma.
RQ2: Are there significant differences between the two groups in knowledge of
glaucoma as a function of whether patients are provided with additional education?
H02: There are no significant differences between the two groups in knowledge of
glaucoma.
Ha2: There are significant differences between the two groups in knowledge of
glaucoma.
RQ3: Is there an interaction effect between time and group in knowledge of
glaucoma as a function of whether patients are provided with additional education?
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H03: There is no interaction effect between the time and group in knowledge of
glaucoma.
Ha3: There is an interaction effect between the time and group in knowledge of
glaucoma.
RQ4: Is patients’ (Group 1 vs. Group 2) adherence to attending a glaucoma
follow-up appointment at T3 dependent on whether patients were exposed to education
about glaucoma?
H04: The patients’ (Group 1 vs. Group 2) adherence to attending a glaucoma
follow-up appointment at T3 is not dependent on whether patients were exposed to
education about glaucoma.
Ha4: The patients’ (Group 1 vs. Group 2) adherence to attending a glaucoma
follow-up treatment at T3 is dependent on whether patients were exposed to education
about glaucoma.
RQ5: Is patients’ (Group 1 vs. Group 2) adherence to using prescribed ocular
medication at T3 dependent on whether patients were exposed to education about
glaucoma?
H05: The patients’ (Group 1 vs. Group 2) adherence to using prescribed ocular
medication at T3 is not dependent on whether patients were exposed to education about
glaucoma.
Ha5: The patients’ (Group 1 vs. Group 2) adherence to using prescribed ocular
medication at T3 is dependent on whether patients were exposed to education about
glaucoma.

11
Nature of the Study
This study was conducted to examine the effect of patient education about
glaucoma through a patient navigator on patient adherence to follow-up care among
Russian Eastern European immigrant patients at a private glaucoma clinic in New York. I
used archival data with an experimental, descriptive design to evaluate whether education
about glaucoma provided by a patient navigator affected patient knowledge of glaucoma,
adherence to medication utilization, and attendance at follow-up appointments.
Determining the experimental descriptive component was by pre- and postlevels of
knowledge, medication use, and attendance to follow-up appointments. The findings
from the study were sufficient to answer five RQs with the independent variable (IV) of
education about glaucoma and the three dependent variables (DVs) of patient knowledge
about glaucoma, attendance at follow-up appointments, and adherence to using
prescribed ocular medications.
Theoretical Framework
The theoretical framework for this study was the transtheoretical model (TTM), or
the stages of change developed by Prochaska and DiClemente in the 1970s (Prochaska et
al., 1992). This model holds that individuals have an enormous capacity to change
harmful or undesirable behavior. This integrative, biopsychosocial model incorporates
the stages through which individuals pass to achieve sustained behavioral change
(Prochaska et al., 2013). The five stages are precontemplation, contemplation,
preparation, action, and maintenance. Researchers have often used TTM to address
behavioral changes, such as smoking cessation, drinking, or overeating. Inherent in this
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model is the recognition and acceptance that change unfolds over time (Prochaska et al.,
2013). TTM serves as a guide to assess an individual’s readiness to act on a new,
healthier behavior, providing knowledge to inform providers about patients’ readiness to
accept new information. Providers can determine whether patients are ready to receive
information about the benefits of implementing the new, changed behavior or whether
this information might overwhelm them.
After receiving a novel diagnosis of glaucoma, which requires highly involved
care and multiple follow-up visits, patients in the asymptomatic early stage might be
resistant to adopting new behavior. TTM helped me determine why some patients are
motivated to change their behavior and others are resistant. In accordance with the TTM
model, because change is a phenomenon of time, bringing these patients back in 1 month
for a follow-up appointment helped me to evaluate the sustainability of behavioral
change.
Definitions of Terms
The following terms received mention in this study:
Adherence to follow-up treatment: I measured adherence to glaucoma follow-up
treatment by the participants’ attendance to a mandatory follow-up examination as
requested by the ophthalmologist. In the past, adherence to glaucoma follow-up treatment
meant attending the follow-up medical exams and agreeing to do the diagnostic testing,
as directed by the diagnosing physician (Movahedinejad & Adib-Hajbaghery, 2016).
Adherence to the use of prescribed medication: Measuring adherence to the use of
prescribed medication was done by the information gathered at the follow-up exam. This
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term describes the extent to which patients administer their glaucoma medications exactly
as prescribed (Newman-Casey, Blachley, et al., 2015; Newman-Casey, Shtein, et al.,
2016).
Education about glaucoma: Education about glaucoma referred to the time the
patient navigator spent with the participants after the ophthalmologist gave them the
diagnosis. This education involved reviewing what POAG uses as an eye model, a
description of how the disease progresses, the meaning of elevated intraocular pressure,
and the importance of adherence to the ophthalmologist-prescribed treatment as well as
the necessity of attending the follow-up exams. All communication was available in
Russian and in English to ensure that patients could comprehend the provided
information.
Glaucoma: Glaucoma includes several complex eye disorders causing permanent
degeneration of the optic nerve and retinal cells, progressing to visual compromise and
eventual blindness (Wiggs & Pasquale, 2017). Marked by an increase in intraocular
pressure, glaucoma is largely asymptomatic, leading to late diagnosis. The disease is the
second-leading cause of irreversible blindness in the United States (Prum et al., 2016).
Glaucoma Knowledge Index: Celebi (2018) developed GKI in assessing
knowledge and awareness of glaucoma among subjects with glaucoma and their normal
first-degree relatives. Administered in the current study at T1, T2, and T3, the GKI
provided information on patients’ knowledge and understanding of glaucoma.
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Knowledge of glaucoma: Evaluating patient knowledge about glaucoma in the
current study was through the GKI (see Celebi, 2018). This instrument is a way to gather
basic information about an individual’s glaucoma knowledge.
Primary open-angle glaucoma: POAG is one of the two main types of glaucoma,
the other being closed-angle glaucoma. POAG affects peripheral vision first, with gradual
and progressive visual field loss unnoticed until significant and permanent damage has
occurred (Greco et al., 2016).
Assumptions
One assumption of this study was that the private glaucoma clinic collected the
archival data correctly, following the appropriate assessment protocol. This assumption
was necessary because I was unable to confirm the means of data collection by the clinic.
Another assumption was that people want to get better and take their medications as
prescribed. I also assumed that patients understood they were participating under their
free will and that if they had refused participation, the clinic would not have withheld or
denied medical care. It was my assumption that the participants were honest in the way
they answered questions and reported the use of the prescribed medications.
Assumptions for the repeated measures analysis of variance (ANOVA) included
normality, sphericity, and homogeneity of variance. Testing assumptions for the chisquare test of independence were that each participant contributed data to only one cell
and that the chi-square was a nonparametric test that did not assume a normal
distribution. More detailed descriptions of the statistical test assumptions are in
Chapter 3.
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Scope and Delimitations
McGregor et al. (2018) found poor outcomes in patients with glaucoma often
attributed to barriers to care, such as limited knowledge about glaucoma, poor access to
and utilization of eye care, lack of adherence to follow-up exams, and inadequate
medication administration. The researchers identified additional barriers to glaucoma
management and treatment to be denying the risk of blindness, lower education level,
poor patient–provider communication, and low health literacy levels. These factors likely
contribute to disparities related to glaucoma detection, treatment, management, and
follow-up eye care. The scope of the current study was to evaluate whether exposure to
education through a patient navigator would have an effect on patient knowledge about
glaucoma as well as patient adherence to follow-up appointments and prescribed ocular
medication. The archival data were from a private glaucoma clinic in New York serving
the Russian Eastern European immigrant population.
One delimitation was that the studied population was limited to high-risk Russian
Eastern European immigrants residing in New York, in geographically isolated
communities with significant socioeconomic disparities. Another delimitation associated
with this study was that although the practice collected data on all patients, I analyzed
data only on new patients with a first-time glaucoma diagnosis. This decision was a
means to eliminate possible contamination by prior diagnosis or education that I could
not evaluate.
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Limitations
The chief limitation of using archival data was the inability to obtain the
information directly; therefore, I could not assume that the results would be entirely
accurate. Using archival data presents a researcher with multiple issues, including the
inability to establish authenticity (Frankfort-Nachmias & Nachmias, 2008). The current
study was limited in the generalizability of findings because the sample, consisting only
of Russian immigrants residing in New York, did not reflect the general population.
Participant data were from one glaucoma specialty practice that used convenience
sampling. There may also have been a positive cultural bias. Because the patient
navigator was a Russian immigrant, participants might have wanted to please her and put
forth more effort than usual. Finally, it was not possible to assess some of the barriers that
might have prevented participants from attending follow-up exams unrelated to
nonadherence. Examples of these components included participant mortality, illness, or
lack of transportation.
Significance
This study was a means to determine whether providing glaucoma education at
the doctor’s visit through a patient navigator increased patient adherence to follow-up
care. I examined the extent to which education by a bilingual patient navigator affected
patients’ knowledge of glaucoma at the time of the exam (T1 and T2) and the 1-month
follow-up appointment (T3). Also investigated was the effect of education on adherence
to follow-up care as determined by the rate of participants’ return for their necessary 1month follow-up exam appointment (T3).
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Vision deterioration and blindness can have devastating effects on quality of life
for patients, their families, and their friends. Irreversible blindness can be frightening,
overwhelming individuals’ capacity to maintain their independence, pay for needed
medical care, retain employment, and provide for themselves and their families. Schakel
et al. (2017) identified links between vision loss and life-altering falls, diminished social
functioning, lower educational attainment, and poor emotional well-being. The authors
also found that individuals with vision impairment are at a higher risk for depression,
anxiety, and other psychological problems. Schakel et al.’s findings showed that as the
population ages, the health care costs and economic burdens related to blindness increase,
indicating the importance of vision for health and social well-being.
The negative health consequences associated with vision loss extend well beyond
the eye and visual system (Glen & Crabb, 2015). The societal costs are substantial,
thereby indicating the need for prevention, especially for diseases in which blindness is
avoidable (Gracitelli et al., 2015). Some of the functional and affective consequences of
vision loss are remediable. The present study contributed to positive social change by
showing the extent to which education provided at the physician’s office by a trained
patient navigator after a glaucoma diagnosis affects patient knowledge about glaucoma
and treatment adherence to follow-up care, both ways to prevent avoidable vision loss.
Summary
The purpose of this quantitative study was to examine the effect of education
about glaucoma through a patient navigator on patient knowledge of glaucoma and
patient adherence to follow-up care. Poor outcomes in patients with glaucoma often stem
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from barriers to care, such as limited knowledge about eye disease, poor access to eye
care, and medication noncompliance (Tan et al., 2018). A limited understanding of the
insidious and asymptomatic nature of glaucoma and the necessity for lifelong treatment
could contribute to follow-up eye care nonadherence. When patients comply with
appropriate treatment, they can manage their glaucoma to prevent blindness.
Understanding the relationship between glaucoma education, participants’ retained
knowledge, and adherence to follow-up care could indicate whether a trained patient
navigator should provide such education as a standard practice at diagnosis.
Chapter 1 contained the purpose, rationale, theoretical framework, and
background of this study. It also included the research questions and hypotheses, nature
of the study, definitions, assumptions, limitations, and delimitations. The chapter
concluded with the significance of the study, the summary, and the potential for social
change. Chapter 2 contains an examination and a review of current literature most
relevant to the research problem of this study.
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Chapter 2: Literature Review
Vision loss significantly impacts participation in daily living, imposes substantial
costs on families, and places a burden on the health system and economy, making it a
significant concern for public health (Congdon et al., 2004; Glen & Crabb, 2015;
Gracitelli et al., 2015; Smith et al., 2019). Vision impairment leads to decreased
involvement in interpersonal interactions and relationships, impacting domestic,
community, and social life (Glen & Crabb, 2015; Gracitelli et al., 2015; Zhang et al.,
2015). The exacerbation of consequential comorbidities, such as an increased risk of
mental health problems and falls, results from the inability to move about unaided (Zhang
et al., 2015). POAG, the most common form of glaucoma, is a chronic, insidious disease
with serious reductions in vision occurring only in the advanced stages (Harasymowycz
et al., 2016; Kapetanakis, 2016). POAG is associated with elevated intraocular pressure
due to aqueous humor outflow dysfunction, and successful treatment is available with
proper medication administrational and adherence to follow-up eye care (Harasymowycz
et al., 2016). About half of glaucoma patients do not adhere to their medications, leading
to poor clinical outcomes and irreversible vision loss (Newman-Casey et al., 2018).
The definition of patient nonadherence is a patient’s failure to follow a prescribed
course of treatment by the attending physician and discontinued or improper use of
prescribed ocular medications (Newman-Casey, Blachley, et al., 2015; Newman-Casey,
Shtein, et al., 2016; Wilhelm et al., 2018). Because therapy adherence is a primary
determinant of POAG treatment success, failure to do so is a serious problem affecting
not only the patient but also the health care system (Wilhelmsen & Eriksson, 2019). A
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significant consequence of nonadherence is that the individual will not obtain an optimal
pharmacotherapeutic benefit, thereby facing increased optic nerve deterioration leading to
preventable blindness (Newman-Casey, Blachley, et al., 2015; Newman-Casey, Shtein, et
al., 2016). Ethnic and age disparities in poor adherence to glaucoma treatment
disproportionately affect older, underserved, vulnerable, and minority populations (Chua
et al., 2015; Newman-Casey et al., 2018). Therefore, it is imperative to focus research on
increasing efforts and understanding the importance of implementing strategies to prevent
avoidable vision loss. Such inquiry could lead to improved eye health among members of
underserved communities who might experience barriers in access to eye care
(Harasymowycz et al., 2016; Kapetanakis, 2016).
The purpose of the current study was to explore the effect of glaucoma education
provided by a patient navigator on patient knowledge of glaucoma, patient adherence to
ocular medication use, and follow-up appointment attendance in the Russian Eastern
European immigrant population at a private glaucoma specialty clinic in New York. In
this chapter, I cover the strategies used to search for literature, the theoretical foundation,
and the study’s framework. The research gaps addressed were the effects of education
provided by a patient navigator on patients’ understanding of their disease, the patients’
attendance during follow-up appointments, and proper utilization of ocular medications.
Literature Search Strategy
I conducted a thorough and exhaustive literature search using Cochrane Library,
MEDLINE Medscape, PubMed, PsycINFO, PsycARTICLES, Google Scholar, and the
Walden University library. I limited the search to sources published between 2015 and
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2020. The initial search was for peer-reviewed articles. Subsequently, I accessed the
CDC and the National Academies of Sciences, Engineering, and Medicine websites for
current information and statistics related to glaucoma prevalence among vulnerable
populations. After screening 8,634 abstracts, I selected 302 articles containing
information on pathophysiology, treatment, and education relevant to ophthalmological
settings specializing in glaucoma treatment. The primary keywords searched were
glaucoma, patient education, compliance, and adherence. I included a combination of
search terms with Boolean operators, such as POAG glaucoma, glaucoma AND patient
education, glaucoma AND treatment compliance, glaucoma AND treatment adherence,
glaucoma AND patient instruction, treatment refusal, treatment nonadherence, patient
persistence, patient acceptance of health care, self-efficacy, self-care, chronic illness
AND self-management, treatment motivation, and stages of change. I did not use any
language restrictions.
Theoretical Foundation
This study’s theoretical framework was the TTM with its stages of change. This
theory was appropriate to understand the process of intentional behavioral change in
patients’ self-management of glaucoma. Noncompliance with follow-up treatment and
medication usage in chronic disorders, such as glaucoma, is a significant obstacle to
helping patients achieve and maintain their eyesight.
Transtheoretical Model
Prochaska and DiClemente developed TTM, or the stages of change model, to
explore the process of change for smoking cessation (DiClemente & Prochaska, 1982,
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1998; Prochaska & Vellcer, 1997). Prochaska and DiClemente were studying the
differences between individuals who experienced quitting smoking on their own versus
quitting with assistance. They created a model of intentional change, focusing on
understanding the decision-making process of the individual.
In a 2-year longitudinal study, DiClemente (1981) examined why some
individuals could quit smoking independently and others could not. TTM applies to
behavior change through educational interventions for patient care (DiClemente et al.,
1985; Prochaska et al., 2013). Individuals with chronic illnesses can struggle with the
awareness that their behavior might be exacerbating the problem; therefore, merely
suggesting they change their behavior might not be sufficient (DiClemente & Velasquez,
1994). Such individuals need to make the conscious decision to change their actions,
producing a positive outcome through sustained behavior change (DiClemente et al.,
1985; DiClemente & Hughes, 1985; DiClemente & Velasquez, 1994).
TTM draws from other theories regarding the process of decision-making, such as
Janis and Mann’s (1977) inquiry into decisional balance and Bandura’s (1977) work on
self-efficacy. Janis and Mann proposed that changing one’s behavior begins with a
decisional balance, when an individual considers consequences from desirable to
undesirable effects before making a decision. This balance is known as the pros and cons
of change. The individual then decides whether to make a behavioral change (Janis &
Mann, 1977). The goal of this process is to facilitate a realistic assessment of behavior
change’s value and potential alternatives. After deciding to change their behavior, the
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individuals will then progress through the stages of change (DiClemente & Prochaska,
1982, 1998; Prochaska et al., 2013).
Bandura’s (1977, 1982, 1986) self-efficacy theory refers to individuals’ belief in
their capacity to execute behaviors necessary to produce specific results. Bandura (1977,
1982, 1986) defined self-efficacy as the core of human functioning, reflecting an
individual’s ability to execute required behavior under manageable and challenging
circumstances. Bandura further discussed that knowledge is not enough for individuals to
complete a task under challenging circumstances; instead, they must have the conviction
that they can complete it (Bandura, 1986, 1997; D. A. Cook & Artino, 2016). Bandura
(1986, as cited in Cook & Artino, 2016) referred to this concept as reciprocal causation,
in which the functioning of one component depends in part on the functioning of the
other. Individuals who score high on self-efficacy scales tend to exert more effort and
persistence in the face of difficulties and adversities than those with lower self-efficacy
(Artino, 2012; Cook & Artino, 2016).
DiClemente and Prochaska (1982, 1998) built upon the concepts of decisional
balance and self-efficacy to propose that changing a behavior is a deliberate process, and
different people are in different stages of change and readiness. Although DiClemente
and Prochaska’s work began with individuals trying to quit smoking, the researchers
noticed that a precipitating event frequently leads to an internal drive to consider any
behavior change. Additionally, their findings indicated that such change happens
predictably. When studying the relationship between individuals’ readiness and their
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ability to quit smoking, DiClemente et al. (1985) observed that participants’ utilized the
processes of change, subsequently identifying a relationship between the two variables.
Upon committing to change, an individual must replace old behavior with new
behavior (Prochaska et al., 1992). Sustainable change does not happen randomly; rather,
it occurs in a predictable way (DiClemente & Velasquez, 1994; Prochaska et al., 1994).
Additionally, sustainable change occurs based on individuals’ ability to implement an
internal change in their behavior due to their readiness and willingness to change
(Prochaska et al., 1994). TTM addresses the five stages that individuals must navigate to
achieve lasting behavior change. The theory provides an understanding of why some
people can change their behavior and others cannot (DiClemente & Prochaska, 1982;
Prochaska et al., 1994).
The Stages of Change
The stages of change in the TTM model are precontemplation, contemplation,
preparation, action, and maintenance. In the precontemplation stage, individuals are
unaware that their behavior might be harmful and have no intention of changing the
behavior (Prochaska & Vellcer, 1997). In this stage, implementing the decisional balance
of pros and cons is a means to discuss the benefits of healthy behavior with the
individuals. Contemplation is when individuals begin to consider the change. In this
stage, the individuals are aware of the problem and desire to change their behavior;
however, they experience ambivalence about implementing change. The preparation
stage is when individuals are ready for change and begin to alter their behavior. In the
preparation stage, encouragement and continued explanation of pros and cons are helpful
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to assist individuals along the continuum of change. The action stage involves individuals
making lifestyle modifications and actively changing their behavior. To successfully
navigate this stage, individuals need self-efficacy to avoid temptation and relapse. Last,
during the maintenance stage, individuals continually channel efforts to maintain
behavior change and prevent relapse.
Individuals move through the process of behavior change through an interplay of
behavioral and experiential processes (Van Cappellen et al., 2018). Although the
concepts of TTM operate in an integrative loop, individuals who relapse will enter the
contemplation stage and resume the process from that point (Grol & Wensing, 2020). For
pervasive internalized change, individuals will have to develop self-efficacy to avoid
relapse.
Current Applications of TTM
TTM has been used in health and medical research to explain or predict a person’s
success or failure in achieving a proposed behavior change (Friman et al., 2017;
Prochaska et al., 2013). TTM has been applied in research related to developing positive
health-behavior changes in chronic disorders in which behavior modifications are critical
to maintaining patients’ well-being. According to prior research, the most consistent
positive outcome of interventions to improve self-care has been improved self-efficacy,
which is an important element of self-management (R. J. Adams, 2010; Friman et al.,
2017). This finding emerged from studies on sustained physical exercise, reducing
obesity based on changing unhealthy eating habits, and medication adherence in diabetic
patients (Friman et al., 2017; Kelley et al., 2016).
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TTM has been a means to understand how individuals attempting to change their
behavior experience stages of readiness to accept such change (Segall, 2018). K. T. Liu et
al. (2018) noted that “movement through these stages often occurs in cyclic rather than
linear patterns because many individuals must make several attempts to change their
behavior before they meet their goals and move to the next stage” (p. 7). In moving
through these stages, people can use different strategies and techniques depending on
their motivation and goals (K. T. Liu et al., 2018; Segall, 2018).
Nigg et al. (2019) examined how TTM predicts behavior change processes and
guides interventions among individuals interested in making changes related to physical
activity. The authors found that intervention efforts focusing on processes to change
cognitions related to barriers in self-efficacy and decisional balance led to sustainable
changes and a renewed focus on the processes. Shakiba et al. (2018) arrived at similar
findings from using a TTM-based intervention to increase fish intake as an intervention
for combating cardiovascular disease in individuals in Iran. Findings from both studies
indicated that when individuals have positive thoughts and attitudes toward the new
behavior and the process of change, they are motivated to stay engaged with the new
behavior, becoming more self-efficacious and less likely to relapse (K. T. Liu et al.,
2018; Nigg et al., 2019; Shakiba et al., 2018). TTM suggests that behavior changes occur
based on knowledge that leads to attitude shifts (DiClemente & Prochaska, 1998).
Limitations of TTM
J. Adams and White (2004) conducted a nonsystematic critical review to
investigate the effectiveness of TTM-based activity promotion interventions. They found
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that a stage-based activity promotion program was effective in encouraging the adoption
of behavioral change in the short term (fewer than 6 months); however, long-term
adherence was limited and disappointing. Additionally, Horwath et al. (2013) suggested
that only individuals who possessed self-liberation demonstrated significant differences
consistently over time, as indicated in their longitudinal study on individuals transitioning
to five or more servings of fruit and vegetables each day.
Bradshaw et al. (2016) supported Horwath et al.’s (2013) findings in a study of
individuals from poorly functioning families, which included high levels of conflict,
disorganization, and weak affective and behavioral control preparing for personal
changes that positively impacted and improved overall family functioning. Bradshaw et
al. found a need to consider other variables when examining individuals’ readiness to
make a sustainable change. The consideration of other variables was because there are no
set criteria for determining a person’s stage of change and no clear sense for how much
time is needed for each stage or how long a person can remain in a stage (J. Adams &
White, 2004; Bradshaw et al., 2016; Horwath et al., 2013).
Additionally, Gourlan et al. (2016) discussed that TTM incorporates a one-sizefits-all approach, which does not suit all individuals and cannot explain variation.
Therefore, TTM is not generalizable to all social and cultural populations. Moreover,
Marshall and Biddle (2001) stated that TTM’s core constructs are of limited use based on
the assumption that individuals make coherent and logical plans in their decision-making
process, which is not always true. Additionally, Marshall and Biddle argued that most
participants’ changes did not align with those predicted.
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Glaucoma
Structure of the Eye
Encompassing several diseases, glaucoma is characterized by increased pressure
of the eye. Glaucoma leads to atrophy of the optic nerve and, if left untreated, causes
irreversible blindness. The human eye splits into two segments: the anterior and the
posterior chamber (Addo et al., 2016). The anterior chamber is in the front segment of the
eye and holds the cornea, iris, ciliary body, and lens immersed in a fluid-like substance
called the aqueous humor (Addo et al., 2016; Sridhar, 2018). The posterior segment
encompasses the back two thirds of the eye and includes the vitreous humor, retina,
choroid, and optic nerve (Addo et al., 2016). The aqueous humor is a clear, thin fluid in
the anterior chamber of the eye continuously produced and drained as it transports
nutrients to the cornea and the lens while giving the eye its shape. The aqueous humor
plays an essential role in eye health because it maintains eye pressure. Any abnormality
or malfunction in the drainage system of the aqueous humor leads to an impaired outflow
of the aqueous humor, causing elevated intraocular pressure.
Measuring intraocular eye pressure is by determining the difference between
atmospheric pressure and the pressure inside the eye (Castro et al., 2016). This number is
a clinical parameter for assessing the health of the eye. The standard for normal eye
pressure is between 12 and 25 mm Hg, with anything equal to or greater than 26 mm Hg
considered elevated intraocular pressure. The elevated intraocular pressure affects all eye
structures, causing optic nerve neuropathy that may lead to blindness. Generation and
maintenance of intraocular eye pressure is by the aqueous humor circulation system
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(Tamm et al., 2015). Secreted from the epithelial layers of the ciliary body, the aqueous
humor exits the eye through the trabecular meshwork or the uveoscleral outflow
pathways. When there is a defect in the outflow pathway, the aqueous humor builds up,
increasing intraocular eye pressure (Tamm et al., 2015).
The Visual Pathway
The visual pathway begins in the posterior segment with the retina and the optic
nerve. The retina, lining the back of the eye, comprises superimposed neurons called rods
and cones, which connect and pass the information to the optic nerve (Fahy et al., 2016;
Nguyen & Ethier, 2015; Wiggs, 2015). Also known as the second cranial nerve, the optic
nerve sends the visual information from the retina to the brain (Freud et al., 2016). The
optic nerve is the only part of the central nervous system that leaves the cranial cavity and
is clinically visible (Freud et al., 2016; Martínez-Marcos & Sañudo, 2019). The optic
nerve gathers information from the retina and sends it to the brain. Composing the optic
nerve are retinal ganglion cells consisting of over one million nerve fibers (Freud et al.,
2016; Martínez-Marcos & Sañudo, 2019), converging at the part of the retina where the
optic nerve exits the eye; this is the optic nerve head (Freud et al., 2016). On retinal
images, the optic nerve head looks like a crater with a cup-to-disc ratio correlated to the
health of the nerve (Orlando et al., 2017).
Glaucomatous Damage
In the presence of glaucoma, elevated intraocular pressure exerts direct
mechanical damage to the optic nerve head, destroying nerve fibers along the outer rim of
the optic nerve (Chaturvedi et al., 2018). This pressure causes the cup to enlarge in a
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vertical oval pattern, increasing the cup-to-disc ratio (Burgoyne, 2015; Chaturvedi et al.,
2018). Optic disc cupping enlargement leads to corresponding sight loss that affects the
peripheral vision only; thus, most affected people are unaware of this disease (Abdullah
et al., 2016; Almazroa et al., 2017). Due to the brain’s ability to compensate for vision
loss, patients might not detect the change until they have lost a significant portion of their
eyesight (Hark et al., 2017; Hark, Waisbroud, et al., 2016). The asymptomatic nature of
glaucoma and the brain’s compensation means patients might not notice vision loss or
experience “tunnel vision” until they have lost 40% of nerve fibers (Hark, Waisbroud, et
al., 2016; Lavinsky et al., 2017). Vision loss from glaucoma is irreversible (Hark et al.,
2017; Hark, Waisbroud, et al., 2016; Lavinsky et al., 2017). The four types of primary
glaucoma are open-angle, angle-closure, normal-tension, and congenital.
Primary Open-Angle Glaucoma
Distinguishing glaucoma entails measuring the angle between the iris makes and
the cornea. In POAG, this angle is open; instead, there is a block in the trabecular
meshwork, a system of canals that allows the aqueous humor to circulate (B. Liu et al.,
2018). Therefore, although the angle is open, once the canals malfunction and the
aqueous humor does not drain properly, the intraocular eye pressure begins to increase
(Kubicka-Trząska, 2020; B. Liu et al., 2018). Nerve damage occurs as the intraocular eye
pressure increases and exerts pressure against the nerve fibers of the optic nerve,
depriving it of oxygen and nutrients (Kubicka-Trząska, 2020). Vision loss from POAG
begins with peripheral vision and slowly moves centrally (B. Liu et al., 2018).
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Most people with POAG feel fine and do not notice a change in their vision at
first because the initial loss of vision is on one side (peripheral), and they maintain visual
acuity, or sharpness, until late in the disease (Weinreb et al., 2016). The lack of
symptoms in POAG delays detection and diagnosis. Typically, POAG progresses slowly;
by the time it becomes symptomatic, severe and irreversible damage has occurred in one
or both eyes (Pan & Varma, 2011; Weinreb et al., 2016). The rate of progression of the
visual field defect varies in patients, and treatment might not completely halt the visual
field loss, despite aggressive therapy (Weinreb et al., 2016).
Minimal data are available on POAG rates in the Russian Eastern European
immigrant population within the United States. However, in 2010, POAG incidence was
highest among this immigrant population, representing 23.9% of those with POAG
worldwide (CDC, 2015; Nowak & Smigielski, 2015; Quigley & Broman, 2006). The
prevalence of POAG pseudoexfoliation glaucoma is much higher among White
Americans. In the United States, the most recent 2010 statistics on POAG
pseudoexfoliation glaucoma are 66% White, 19% Black, 8% Hispanic, and 7% other
races (National Eye Institute, 2019). Because Russian Eastern European immigrants
identify as White Americans, it is fair to assume they are part of the 66%. Genetic defects
account for a significant prevalence of this disease in some ethnic and racial groups.
More specifically, a strong genetic association has emerged with the lysyl oxidase-like 1
(LOXL1) gene in many POAG patients with pseudoexfoliation glaucoma (Janjua et al.,
2017). Although genetic predisposition for phenotypic expression of glaucoma is better
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understood, intraocular eye pressure is currently the only modifiable risk factor to prevent
progressive optic neuropathy and blindness from glaucoma (Mohsen et al., 2016).
Diagnosing POAG
Although elevated intraocular pressure is a consistent risk factor for the presence
of glaucoma, several population-based studies showed intraocular pressure to be lower
than 22 mm Hg in 25% to 50% of individuals with glaucoma (Behkam et al., 2019).
Therefore, increased intraocular pressure may predispose individuals to POAG. However,
the mere presence of elevated intraocular pressure is insufficient for the diagnosis
(Behkam et al., 2019; Mohsen et al., 2016). A full ophthalmologic workup is necessary to
diagnose POAG accurately. A comprehensive eye exam involves intraocular pressure
measured with Goldmann applanation tonometry, the international standard for ocular
pressure assessment in ophthalmic research and clinical practice, gonioscopy, optic nerve
assessment visual field testing (Mohsen et al., 2016). Pachymetry, the measurement of
central corneal thickness, can help interpret intraocular pressure measurements and
stratify the patient’s risk of developing glaucomatous visual field defects. The
ophthalmologist can assess the extent of optic nerve involvement or damage via direct
ophthalmoscopeIndirect ophthalmoscopy allows the ophthalmologist to view
glaucomatous changes, including cupping or other signs of damage on the optic nerve,
such as optic nerve hemorrhage or focal loss of the nerve fiber layer.
The extent of diagnostic involvement is exhaustive, with diagnosis requiring a
highly trained ophthalmologist who is a glaucoma specialist. General ophthalmologists or
those not specializing in glaucoma frequently underdiagnose glaucoma, either missing
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the diagnosis or as a result of patients missing their appointments (Kabat & Sowka, 2016;
Nayak et al., 2011). Due to the narrowness of this subspecialty and lengthy training time,
few glaucoma specialists are available in low socioeconomic and underserved areas
(Rodgers et al., 2017). The absence of specialists coupled with geographic
maldistribution of practice locations leaves many underserved, vulnerable, and at-risk
populations without care to prevent late-stage POAG glaucoma, leading to blindness.
Treating POAG
At present, the only intervention proven effective for treating POAG and ocular
hypertension is lowering intraocular eye pressure to prevent further progression of optic
nerve neuropathy and visual loss (Weinreb et al., 2018). The American Academy of
Ophthalmology Preferred Practice Pattern recommends lowering the intraocular pressure
to a level that will slow the disease progression and prevent functional impairment from
the disease (Feder et al., 2016; Glaucoma Research Foundation, 2018). The most
effective way to achieve these recommendations is by using pressure-lowering topical
ocular medications (Y. Liu & Allingham, 2017). Often the first line of medical therapy,
prostaglandin analogues reduce intraocular pressure by lowering outflow resistance,
resulting in increased aqueous humor flow through the uveoscleral pathway (Diaconita et
al., 2018; Nguyen & Ethier, 2015). Topical ocular medications are the most common due
to their convenience, simplicity, and noninvasive nature, and the patient’s ability to selfadminister (Diaconita et al., 2018; Weinreb et al., 2020). However, these medications can
cause local adverse effects, such as conjunctival hyperemia, elongation and darkening of
eyelashes, loss of orbital fat, and periocular skin pigmentation (Diaconita et al., 2018).
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Adverse effects of glaucoma medications are frequent, occurring immediately or
much later (Weinreb et al., 2020). The most common ocular complaint with these
medications is transient stinging and burning (Davis et al., 2018; Farkouh et al., 2016).
Other frequently reported symptoms include fluctuating vision, dry and itchy eyes, and
retinal detachment (Nguyen & Ethier, 2015; Weinreb et al., 2020). These symptoms are
bothersome but mostly toleratable. Approximately 80% of eye drops can pass through the
nasolacrimal duct into the nasal mucosa and its microvasculature, causing systemic side
effects (Farkouh et al., 2016; Stavert et al., 2015). These side effects include intestinal
cramps, tinnitus, hearing dysfunction, diarrhea, bronchospasm, cardiac irregularities,
tachycardia, arrhythmia, elevated blood pressure, depression, lethargy, fatigue, kidney
stones, and anaphylaxis (Farkouh et al., 2016; Janjua et al., 2017; Stavert et al., 2015).
Laser or incisional surgeries are necessary if medications no longer adequately
work and other treatment modalities cannot keep the intraocular pressure under control
(Elhofi & Lolah, 2017). For extremely nonadherent patients or those with severe disease,
surgery is required (Sahoo et al., 2018). Trabeculectomy is the most-performed incisional
surgical procedure to lower intraocular pressure. This surgical glaucoma procedure
disrupts the globe’s integrity and produces a plethora of complications, most of which are
vision-threatening (Elhofi & Lolah, 2017; Sahoo et al., 2018; Yook et al., 2018).
Therefore, postoperative success rates are low with the possibility of developing a flat
anterior chamber, infection, scarring, bleeding, and complete vision loss (Yook et al.,
2018).
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Barriers in Adherence Treating POAG
Medical pharmacological treatments are effective in controlling glaucoma
(Mehuys et al., 2019; Souto et al., 2019). Unfortunately, patient adherence to glaucoma
treatment and medication is an ongoing challenge (Mehuys et al., 2019). Frequent
glaucoma follow-up visits are essential to evaluate patients’ response to the ocular
medications and to assess any adverse side effects (Feng et al., 2016; Mehuys et al.,
2019). Such frequent follow-up visits have served as obstacles to proper disease
management (Lazcano-Gomez et al., 2016; Mehuys et al., 2019). Moreover, unlike oral
medicines, eye drops require patients to use proper techniques for successful
administration (Lazcano-Gomez et al., 2016). Poorly established eye drop instillation and
nonadherence lead not only to reduced treatment effectiveness but also increased costs
from chronic disease (Feng et al., 2016; Souto et al., 2019). More than half of POAG
patients omitted 10% of their doses, while another 15% omitted half of their doses (Gao
et al., 2018; Souto et al., 2019). Newman-Casey, Robin et al. (2015) found that nearly
half of individuals filling glaucoma prescriptions discontinued ocular hypotensive
therapies within 6 months. Improper instillation of ocular medications can also lead to
eye infection and other traumas due to overdose or touching the eye with the eye drop
container (Bacon et al., 2016; Gao et al., 2018). Poor tolerance and systemic side effects
of ocular medications are crucial noncompliance issues, especially when the primary
disease is asymptomatic (Feng et al., 2016; Gao et al., 2018).

36
Physician–Patient Therapeutic Relationship
The physician–patient relationship is a keystone of care, the medium for
establishing a positive therapeutic climate and alliance to achieve a common goal
between practitioner and patient (Alkureishi et al., 2016). In the context of this
relationship, practitioners collect and evaluate clinical data, offer education and
diagnoses, achieve compliance, and provide healing, patient activation, and support
(Alkureishi et al., 2016). The patient–practitioner connection is a dynamic relationship
evolving much like health care, from traditional to electronic (Cajander & Grünloh,
2019). Physicians and health care providers have a significant impact on a patient’s
compliance and therapeutic effects; therefore, treatment discussion and communication
are integral to any diagnosis (Colloca, 2017; Hansen & Zech, 2019). When making a
chronic diagnosis or dispensing information on therapeutic benefits, the provider’s choice
of words, clinical setting, and transparency of expected side effects will impact the
patient’s emotional and physical response (Heisig et al., 2015; Vögtle et al., 2016). The
way physicians communicate a diagnosis and discuss possible symptoms and treatment
can shape the course of the illness for years, directly affecting the disease progression and
outcome (Colloca et al., 2018; Howick et al., 2018). In a study on implications of placebo
effects for clinical practice, Evers et al. (2018) found that providers’ positive framing
resulted in advantageous neurobiological and psychological mechanisms of expectancies
and increased adherence to treatment, particularly among patients with negative treatment
beliefs.

37
The widespread implementation of electronic health records helped create
convenience and care continuity, promote patient participation, and improve health
outcomes (Cajander & Grünloh, 2019). However, there is little proof about the
development and creation of physician–patient collaborative processes with electronic
health record implementation (Cajander & Grünloh, 2019; Zulman et al., 2020).
Concerns have arisen over physicians paying more attention to the patients’ e-chart on
the computer screen than to the real patient during a clinical interaction (Alkureishi et al.,
2016). Although electronic health records provide infrastructure for billing purposes, the
physicians face obstacles in completing the electronic chart and often do so while a
patient is still in the exam room (Alkureishi et al., 2016). The workflow process prevents
the patient from checking out and making a follow-up appointment until the physician
has completed and closed that part of the chart. Although created to help physicians
complete charts faster and make billing easier, electronic health records introduced a
clinical burden that has become a leading cause of physician burnout (Collier, 2017;
Ehrenfeld & Wanderer, 2018).
Mounting income pressures and economic forces driving the health care industry
to focus on productivity, coupled with increased administrative demands of electronic
health records, have led to a decline in quality time between physicians and patients
(Rider et al., 2018). The 1995 Commonwealth Fund Survey found that 41% of physicians
reported a decline in the amount of time spent with patients (Dugdale et al., 1999).
Reduced exam room time significantly impedes the human connection central to clinical
care, exacerbating physician and patient dissatisfaction (Zulman et al., 2020).
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Furthermore, these deteriorating physician–patient relationships create a lack of empathy,
leading to worsening illness on both emotional and physiological levels, known as the
“nocebo response” (Ehrenfeld & Wanderer, 2018; Rider et al., 2018).
Nocebo response is the opposite of a placebo effect and has a substantially
negative impact on patient adherence to medical treatment (Barsky, 2017). Nocebo
effects can result from negative experiences and outcomes deriving from the clinical
encounters (Czerniak et al., 2016). The content and the means of presenting information
to patients in a clinical setting during a diagnostic procedure influence the nocebo
response (Nestoriuc et al., 2016). These effects can also emerge in clinical practice by
negative expectations relating to discussions of possible side effects from prescribed
medications as well as treatments and progression of the disease (Bartley et al., 2016;
Petrie & Rief, 2019). The nocebo effect has been apparent in situations with little time for
physicians to spend with patients, a pervasive lack of discussions and conversations, a
language or cultural barrier, and no opportunity for patients to ask questions and receive
education about their illness (Petrie & Rief, 2019). Patients experiencing a nocebo effect
tend to have negative psychological and neurobiological mechanisms of accepting their
diagnoses, subsequently becoming nonadherent or even discontinuing an appropriate
therapy. The nocebo effect has considerable costs in terms of impaired patient quality of
life, nonadherence, and adverse health outcomes (Rezk & Pieper, 2017).
Factors Leading to Glaucoma Treatment Nonadherence
Despite the availability of effective glaucoma therapies, such as ocular
medications and adherence to follow-up care to reduce vision loss from glaucoma,
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nonadherence in patients is as high as 80% (Robin & Muir, 2019). Poor adherence and
poor clinical outcomes disproportionately impact the most vulnerable members of
society, including culturally isolated, older, and minority populations (Hark et al., 2019;
Newman-Casey et al., 2018). Adherence is a complicated multifactorial phenomenon
influenced by multiple variables, including patient, therapy, condition, health system, and
socioeconomic factors and comorbidities (Robin & Muir, 2019). The World Health
Organization (2003) defined adherence as “the extent to which a person’s behavior taking
medication, following a diet, or executing lifestyle changes corresponds with agreed
recommendations from a health care provider” (p. 3).
Factors that influence adherence to glaucoma medications derive from multiple
sources. Scholars have consistently identified significant barriers to adherence, including
poor communication between physicians and patients, patients’ lack of knowledge about
the long-term effects of glaucoma, problems reading instructions, difficulty with drops
instillation or poor technique, forgetting to take the medication, polypharmacy, health
care/medication costs, and medication-related adverse effects (Tamrat et al., 2015).
Poor Education and Patient Knowledge
Inadequate knowledge about glaucoma, glaucoma treatment, and consequences of
deficient treatment may all contribute to nonadherence or nonpersistence (Robin & Muir,
2019). Celebi (2018) conducted a cross-sectional survey of glaucoma knowledge in
patients and their first-degree relatives, finding that 50% of nonadherent respondents
cited knowledge about glaucoma as a barrier. Similar to other asymptomatic chronic
illnesses, such as systemic hypertension, patients with glaucoma do not have clear
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endpoints that tangibly signal improvement. Patients may not fully understand eye
pressure and its effects (Celebi, 2018).
Research shows that a tailored approach centered around the patient with initial
education about glaucoma and the importance of using the eye drops can improve
motivation and compliance (Tse et al., 2016). Physicians who are burdened by economic
pressures, time-consuming electronic health record platforms, and overbooked schedules
due to an overwhelming shortage of glaucoma specialists face significant time constraints
to deliver effective educational interventions (Alkureishi et al., 2016). Inadequate time
creates a void in the current paradigm of how a single physician is responsible for
medical decision-making, surgical intervention, counseling and educating patients, and
coordinating care in a complex medical system (Newman-Casey et al., 2018; Tse et al.,
2016).
To address the inadequate time providers spend with patients, Newman-Casey et
al. (2018, 2020) created a technology-based, individually tailored behavior change
program designed to motivate people with glaucoma to improve their medication
adherence. The implemented program consisted of paraprofessionals providing brief,
glaucoma-specific motivational interviewing and counseling. The intervention did not
improve patients’ eye drop instillation self-efficacy or overall health activation. The time
paraprofessionals spent with patients was brief, not education-focused, and not offered in
a culturally competent environment where non-English speaking patients received
information in their native language (Newman-Casey et al., 2020). The findings indicated
that lower income, lower educational attainment, and a higher level of glaucoma-related
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distress all predicted less adherence to glaucoma medications. Shah (2018) provided
leaflets and online tools to patients to evaluate the effectiveness of such educational tools;
however, these tools did not produce long-term adherence. Shah identified a need to relay
educational information needs verbally, as many patients respond favorably to
discussion-based conversation and prefer a personalized, one-on-one consultation with
their provider.
Difficulties With Ocular Medication Instillation
A critical contributing factor to continued vision loss from glaucoma is poor
medication adherence (Newman-Casey, Blachley, et al., 2015). Newman-Casey,
Blachley, et al.’s (2015) literature review of glaucoma treatment showed dismal rates of
medication adherence; in one longitudinal 4-year study, only 48% of 1,234 glaucoma
patients filled half of their prescribed medications. Medication adherence is difficult to
measure, especially when based on patient self-reports. Prior studies on medication
adherence indicated three main reasons for medication nonadherence (Ehrlich et al.,
2019; Newman-Casey et al., 2019). Twenty to 30% of patients never fill the first
prescription, and 50% never fill the second prescription. Between 20% and 50% of
patients try to use their glaucoma medications but fail to instill them correctly (NewmanCasey et al., 2019). Therefore, it is critical to reassess patients during their follow-up
appointments to differentiate eye drop efficacy from lack of adherence (Kim et al., 2018).
A patient might report adherence but use a medication incorrectly or not take any
medication due to difficulty self-administering drops (Newman-Casey et al., 2019).
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Numerous studies in the United States and other countries have shown poor
technique to be a considerable concern in nonadherence (Newman-Casey, Robin, et al.,
2015). Newman-Casey, Robin, et al. (2015) identified that worsening glaucoma is
associated with changes in visual function, but these occur gradually, often without
patients’ awareness. The only way to truly discern if the glaucoma is under control is
through a series of follow-up appointments where the ophthalmologist can compare
subsequent test results to the baseline and keep checking the stability of the intraocular
eye pressure (Konstas et al., 2018). However, these visits might be as frequent as every
few months, with a considerable wait time. Konstas et al.’s (2018) findings indicated that
infrequency could further contribute to nonadherence, as patients might not understand
the value of these visits.
Frequently, patients may need more than one medication regimen. Ocular surface
disease is extremely common in glaucoma patients and a significant cause of
comorbidity, requiring more than one medication treatment (Zhang et al., 2019). In these
situations, nonadherence is related to patients receiving multiple medications.
Researchers found that persistence declined as the number of medications increased, and
compliance with medications faltered due to side effects and a lack of symptoms
secondary to glaucoma itself (Weinreb et al., 2018; Zhang et al., 2019). Many patients are
unconcerned about worsening glaucoma because of the lack of symptoms, whereas others
might become fatalistic, give up, and stop taking their medication (Colombo et al., 2016).
Both apathetic and fatalistic perceptions regarding the possibility of worsening glaucoma
could cause insufficient motivation to adhere to treatment regimens.
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Approaches to Improve Adherence and Persistence
Increasing the proportion of people who adhere to glaucoma therapy could help
delay disease progression as well as subsequent vision loss and reduced quality of life.
Researchers have conducted studies to address health-promoting interventions that might
improve adherence to glaucoma treatment (Wolfram et al., 2019). Some of these
interventions include educational and instructional videos about glaucoma and ocular
medication instillation, eye drop administration trackers, automatic medication refills sent
to the pharmacy, telephone calls and texts to remind patients to take their drops, and
counseling sessions with motivational interviewing and behavioral modification
techniques (Newman-Casey, Robin, et al., 2015). Many of these interventions had a
substantial impact on improving medication adherence in the short term (Slota et al.,
2015). Telephone counseling proved to be not as effective as counseling offered in
person; however, few medical offices were equipped to offer in-person counseling.
Moreover, interventions with adequate time to spend with the patients to address each
person’s needs were difficult and not sustainable for busy ophthalmological practices. To
date, no standardized approaches to improving support for glaucoma patient selfmanagement and developing health-promoting behavior have emerged (Fudemberg, Lee,
et al., 2016; Slota et al., 2015; Wolfram et al., 2019).
For an intervention to be successful and sustainable, patients’ perceived severity
of the disease and benefits of treatment must be higher than their experiential lack of
symptoms and bothersome medication side effects (Killeen et al., 2020; Wolfram et al.,
2019). Time spent educating patients should include a few key factors. The patient must
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understand that glaucoma causes vision loss, the treatments offered by their doctor could
mitigate this effect, and the barriers to following their physician’s recommendation are
not difficult to overcome and outweigh the perceived benefit of treatment (Davis et al.,
2019). However, patient education becomes a time-consuming process for which current
ophthalmology practices are not equipped. Additionally, physicians and staff do not have
the time or resources to accommodate this level of involved patient care, creating a
clinical void in the health care service delivery.
Challenges of Health Care Delivery in Nonacculturated Russian Immigrant
Communities
Rates of international migration have reached unprecedented levels in the United
States and worldwide. The United States has experienced a massive immigration wave,
its largest in the19th and early 20th centuries, with New York facing a rapidly changing
demographic landscape and an increasingly multiracial and multicultural population
(New York City Department of Health and Mental Hygiene [NYC Health], 2020). New
York, has a dense immigrant residential population stratified by pockets of residential
nonacculturation. Acculturation happens when groups of individuals from different
cultures come into continuous, firsthand contact, resulting in the assimilation of one
group into the other. Eastern European Russian immigrants 65 years and older become
Medicaid and social assistance beneficiaries with opportunities for subsidized housing,
which inadvertently stratifies immigrant populations, creating dense, insular pockets with
no need to acculturate. Such homogeneous and concentrated cultural pockets could
appear at sub-zip code levels in neighborhoods throughout the borough. Additionally,
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homogeneous neighborhood composition creates enclaves of living and drives the need to
create service delivery in culturally adherent standards (NYC Health, 2020). For instance,
the area once known as Brighton Beach has received the moniker “Russian Beach” due to
most of its residents being Eastern European Russian immigrants.
Language presents a challenge in serving this community, as the majority of the
population’s service area speaks primarily Russian (NYC Health, 2020). Insular
neighborhoods resistant to acculturation face challenges and barriers to health care, such
as linguistic incompatibilities, insurance eligibility, familiarity with the U.S. health care
system, and the ability to connect with and understand non-Russian care providers (Kim
et al., 2015; NYC Health, 2020).
Older immigrant populations already experience adaptation challenges because of
cultural gaps between their values and those of the host society (Kim et al., 2015). Such
experiences also result in a lack of social support from the host society, family conflicts,
and racial discrimination. Individuals strive to maintain their cultural heritage and
cultural identities, subsequently leading to low acculturation. Although prior research
shows that advanced cultural connectedness, community strength, and participation help
older immigrants gain a sense of social, cultural, and psychological significance, it
inadvertently promotes nonacculturation (Kim et al., 2015; Wright-St. Clair et al., 2018),
directly affecting health care delivery.
Older Russian immigrants experience difficulty seeking medical help from nonRussian-speaking providers due to language barriers and cultural misunderstandings.
Access to high-quality eye and vision care is a component of a comprehensive population
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health approach to reduce vision impairment (Lee, 2017; McKeever et al., 2019). The
present health care landscape offers health care services from Russian providers;
however, few are ophthalmologists, and even fewer are glaucoma specialty providers. In
addition to the lack of Russian-speaking glaucoma ophthalmology providers, conflicting
clinical practice guidelines create different standards, leading to confusion regarding
what care is needed and when. Limited integration among and between clinical public
health series combined with insufficient cross-disciplinary training of the workforce
negatively affects the diagnosis and follow-up care. Additional population distrust toward
non-Russian-speaking providers hampers the ability to improve care quality by applying
continuous quality improvement programs.
Filling the Gap in Glaucoma Care Delivery
Health care provision disparities occur when beneficial medical interventions are
not shared equally and arise from a complex interplay of economic, social, and cultural
factors (Thornton et al., 2016). Principal causes of such health disparities stem from
overlapping poverty, culture, and social injustice. These causal factors impact all aspects
of the health care continuum, from prevention, detection, diagnosis, treatment, and
survival to the end of life. Disparities occur principally in individuals or populations who
experience insufficient resources, culturally influenced behavior, and/or social inequities.
Any successful intervention must entail considering related population characteristics and
sociocultural environments of proposed service delivery; otherwise, even the most
efficacious interventions cannot achieve desirable outcomes (Dye et al., 2019; Thornton
et al., 2016). Such considerations are not easy, as they might challenge the use of
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traditional or mainstream interpretations of standard evaluation techniques because of the
implications of being a socially disadvantaged population (Dye et al., 2019).
Preventing vision loss and treating vision disorders begins with understanding
gaps in eye care delivery, especially for older Russian immigrant adults at high risk for
vision loss (Lee, 2017; McKeever et al., 2019). Demographic shifts in the U.S.
population alter the prevalence of various conditions associated with vision loss because
these conditions vary by race, culture, and ethnicity. Prior scholars have not demonstrated
long-term adherence to glaucoma therapy in diverse populations, although short-term
educational strategies have been successful (Newman-Casey et al., 2020). Successful
educational interventions require time for demonstration and conversation, ocular drop
instillation presentation and practice, and medication side effect discussion. When
delivered in culturally competent ways and in the patients’ preferred language, the
interventions are most effective (Dye et al., 2019). Due to a substantial lack of
specialized Russian-speaking glaucoma providers, office space limitations, no dedicated
professional specialty to provide such service, asymptomatic nature of glaucoma, long
waiting times to see the ophthalmologist, and a plethora of side effects associated with
ocular medications, patients continue to be nonadherent to their glaucoma treatments.
Professional Service Gap
The field of ophthalmology is unique in its lack of hiring nurses. Although there
is a positive correlation between nurse competency and patient care quality, the visibility
of this career path is not yet widely accepted (Abid et al., 2018; Aw & Dury, 2016;
Moradi, 2016). The eye care field consists of ophthalmologists who are medical doctors
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who diagnose, prescribe, and operate and optometrists who specialize in some diagnosis
and treatment but mostly refractive disorders (Cicinelli et al., 2020; Shamanna et al.,
2005). Opticians fit and make glasses; ophthalmic technicians perform intakes, triages,
and work up patients; ophthalmic photographers take various images of patents’ eyes and
perform scans and visual fields (Cicinelli et al., 2020; Shamanna et al., 2005).
Educating patients about their ocular conditions has long been the provider’s
responsibility (Rosdahl et al., 2014; Williams et al., 2016). In a survey of patients’
preferences in receiving diagnosis and care instructions, Rosdahl et al. (2014) found that
55% of respondents preferred one-on-one educational sessions from their eye care
providers. However, for various reasons, ophthalmologists are no longer able to fulfill
that role. Another consideration was ophthalmic nursing. Although ophthalmology is a
subspecialty in a nursing curriculum, there is little room for ophthalmic nurses in clinical
settings. They usually prefer the highly clinical interactions less available in ophthalmic
settings (Moradi, 2016). Additionally, there has been no evaluation of the costeffectiveness of the registered nurse position. Historically, patient navigators are useful to
improve outcomes in vulnerable populations by eliminating barriers to timely diagnosis
and treatment of cancer and other chronic diseases (Pratt-Chapman, 2016).
Patient Navigators
The first patient navigation program was in 1990 in Harlem, New York, created
by the president and founder of the Harold P. Freeman Patient Navigation Institute
(Freeman, 2006; Freeman et al., 1995; Freeman & Rodriguez, 2011). The program’s
original goal was to reduce cancer mortality by eliminating financial, communication,
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medical system, psychological, and logistical barriers to screening, diagnosis, treatment,
and supportive care (Freeman, 2006; Freeman & Rodriguez, 2011; Valaitis et al., 2017).
The scope of patient navigation has evolved to become a patient‐centric health care
service delivery intervention with the principal purpose of eliminating barriers occurring
across the health care continuum (Valaitis et al., 2017). This program has expanded to
application across the health care continuum to help patients with chronic diseases other
than cancer in such areas as prevention, detection, diagnosis, treatment, education,
supportive care, and end-of-life care.
In recent years, most navigation programs have been means to help patients
overcome barriers to care, such as challenges with health literacy or fluency in the
English language affecting comprehension of diagnosis and treatment, lack of
transportation, or insufficient insurance coverage (Ko et al., 2019). Patient navigators
have also strived to build and strengthen the communications and relationships between
patients and health care professionals while addressing psychosocial concerns of patients
and their families (Ko et al., 2019; Lopez et al., 2019). Another common role of
navigators has been to close the gaps in the health care system by tracking patient care
and ensuring smooth handoffs from one provider to another (Kline et al., 2019; Ko et al.,
2019). Many interventions have been in predominantly minority and economically
underserved areas, often in urban cancer centers (Lopez et al., 2019).
Inadequate communication between clinician and patient is a common contributor
to chronic health care problems. Patient navigators can address these concerns, which are
often due to a patient’s lack of fluency in English, health literacy, or self-efficacy or to
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clinician insensitivity. (Kline et al., 2019; Lopez et al., 2019). Wells et al. (2018)
conducted a nationwide cross-sectional study to assess the roles of patient navigators,
successful patient navigator characteristics, and work settings. In community-based
organizations and chronic health care offices, navigators frequently made arrangements
and referrals to services, provided care coordination and education, and assisted with
obtaining basic needs and addressing the barriers preventing patients from obtaining
health care (Wells et al., 2018). Pratt-Chapman et al. (2015) found that a clinical degree
is not necessary for a successful patient navigator; instead, the most important
qualification was being a “cultural broker and interpreter” from the serviced
communities. Additionally, patient navigators with certain personal qualities, such as
being personable and willing to improve the lives of others, have the greatest success
with patient treatment compliance (Duggleby et al., 2016; McMullen et al., 2016;
Ustjanauskas et al., 2016). Wells et al. identified the clinical specialties that used patient
navigators, including oncology, diabetes, cardiovascular disease, asthma, chronic
obstructive pulmonary disease, and HIV/AIDS. Most of these conditions are chronic, like
glaucoma.
There has been little evaluation of patient navigators’ effectiveness in
ophthalmological settings. Newman-Casey, Blachley, et al. (2015) evaluated the
effectiveness of nonphysician presurgical counselors teaching patients about cataracts
and cataract surgery in improving patient knowledge, decisional conflict, and patient
satisfaction outcomes. Findings indicated that increased use of high-quality counseling
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might reduce decisional conflict about cataract surgery among patients with more limited
access to health care.
Although not a patient navigator program, Newman-Casey, Blachley, et al.’s
(2015) research was close to a concept study regarding surgical interventions. Hark,
Johnson, et al. (2016) evaluated whether the use of a patient navigator altered adherence
to follow-up eye care appointments in community-based versus office-based settings.
Findings from their study showed that help from a patient navigator did not increase the
long-term likelihood of keeping follow-up appointments in an office-based setting. One
limitation of this study was the recruitment of subjects from a prior glaucoma study, the
findings of which showed patient familiarity with the research staff, which likely
increased appointment adherence across all groups. Last, the participants were selfselected and might not reflect the general patient population.
Reasons Providing Education Has Not Worked in Prior Research
Nonadherence to medical treatment is a problem that has gained enormous
attention. Researchers have conducted extensive studies to identify the cause of the
problem and solutions for nonadherence. Some evidence has shown that educating
patients on glaucoma management may improve medication adherence (Rao et al., 2016).
Of eight studies that focused on improving patient knowledge to increase adherence to
glaucoma medications, Newman-Casey, Dayno, et al. (2016) found that five showed
significant short-term improvements in adherence after educational interventions, two
showed nonsignificant improvements, and one showed no improvement in patients who
had relatively high baseline knowledge of glaucoma. Because the studies used vastly
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different interventions, it was difficult to determine which aspects of each educational
intervention had the most significant impact on medication adherence (Robin & Muir,
2019). According to Newman-Casey, Dayno, et al., respondents reported various
difficulties administering eye drops, including aim (24%); controlling the number of
drops dispensed (18%); holding steady while squeezing the bottle (10%); flinching or
blinking, causing the drops not to enter the eye (10%); and squeezing the bottle (5%).
Although providing patient education could theoretically remedy all these difficulties, the
researchers asserted that many studies had not supported these results in the long term.
Educational interventions have shown some significant improvement short term;
however, this might be due to the Hawthorne effect.
The Hawthorne effect refers to research participants altering their behavior based
on the awareness of being observed and participating in the trial (Parsons, 1974).
Therefore, the Hawthorne effect could significantly affect the generalizability of clinical
research findings. Parsons (1974) described the Hawthorne effect from a study in which
subjects’ response rates rose without manipulating the IVs. This study created an interest
in confounding variables because of some aspect of the experiment itself, such as subject
observation. Goodwin et al. (2017) examined the degree to which the Hawthorne effect
altered outpatient visit content. Although an observer’s presence had little effect on most
patient‐physician visits, it appeared to affect a subgroup of vulnerable patients. Because
most participants in prior studies about glaucoma interventions were lower-income,
minority, and vulnerable populations, it is possible to assume that some part of short-term
behavior change could be due to the Hawthorne effect.
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Summary and Conclusion
POAG leads to progressive damage to the optic nerve and is the leading cause of
irreversible blindness worldwide (Abdull et al., 2016). Blindness from glaucoma is
avoidable with early diagnosis and appropriate, sustained, life-long treatment (Abdull et
al., 2016; Kyari et al., 2016). With adequate knowledge, adherence to follow-up care, and
proper ocular medication utilization, patients can prevent blindness from this disease.
However, studies have shown that many patients fail to adhere to treatment
recommendations and end up losing most of their vision (Nowak & Smigielski, 2015).
Measuring adherence to medical and behavioral interventions is important to clinicians
and researchers, as inadequate adherence can reduce an intervention’s effectiveness.
In this quantitative study, I explored the effects of education about glaucoma
provided by a patient navigator on patients’ knowledge about glaucoma, adherence to
follow-up visits, and ocular medication utilization. A private glaucoma clinic in New
York gathered data for its internal cost-benefit analysis of hiring and training a patient
navigator.
In Chapter 3, I describe the research method, purpose of study, research design,
and rationale. I discuss the target population, sample and sampling procedure, and
procedure used for the collection of and access to archived data. Finally, Chapter 3
presents the instrumentation and operationalization of constructs, ethical procedures, and
threats to internal, external, and statistical validity.
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Chapter 3: Research Method
The purpose of this study was to determine whether education about glaucoma
provided by a patient navigator affected patient knowledge about glaucoma, patient
adherence to follow-up visits, and medication utilization among Russian Eastern
European immigrant patients at a private glaucoma clinic in New York. This study
entailed the use of archival data with a longitudinal design. In this chapter, I describe the
research design and rationale, define the IV and DVs, and identify the research design
and its relevance to the study. Chapter 3 presents the target population, sampling, sample
size, procedure used for collecting archival data, and data analysis using Statistical
Package for the Social Sciences (SPSS). Finally, I identify resource constraints associated
with the research design and describe how this design is consistent with the approach
needed to advance knowledge in the field.
Research Design and Rationale
In this quantitative study, I attempted to identify whether there was an effect of
education about glaucoma provided by a patient navigator on patient knowledge about
glaucoma, patient adherence to follow-up visits, and ocular medication utilization. A
private glaucoma clinic in New York gathered data to analyze the costs and benefits of
hiring and training a patient navigator. The clinic provided the information to me in an
Excel spreadsheet. From the archival data, I examined patient answers collected at three
time points, making this a longitudinal retrospective study design. The IV was exposure
to education about glaucoma through a patient navigator, and the DVs were patient
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knowledge of glaucoma, patient adherence to follow-up visits, and patient utilization of
prescribed ocular medications.
Longitudinal cohort studies are appropriate to evaluate education or other medical
research interventions because the design allows the researcher to follow change over
time among particular individuals within the cohort (Caruana et al., 2015). The
longitudinal cohort study design enables researchers to establish a sequence of events to
identify and relate events to a particular exposure. I sought to evaluate whether exposure
to education impacts patient outcomes, making the longitudinal cohort design the most
appropriate for this study. Disadvantages of longitudinal cohort studies include
incomplete or interrupted follow-up of individuals and attrition over time, and an
inability to control individual exposure to an occurrence, both of which might affect the
outcome (Caruana et al., 2015).
Research Questions and Hypotheses
This quantitative study was a means to explore whether exposure to education
about glaucoma provided by a patient navigator impacts patient knowledge about
glaucoma, patient adherence to follow-up visits, and ocular medication utilization. The
RQs and their corresponding hypotheses for this study were as follows:
RQ1: Are there significant differences between pretest and posttest in knowledge
of glaucoma as a function of whether patients are provided with additional education?
H01: There are no significant differences between pretest and posttest in
knowledge of glaucoma.
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Ha1: There are significant differences between pretest and posttest in knowledge
of glaucoma.
RQ2: Are there significant differences between the two groups in knowledge of
glaucoma as a function of whether patients are provided with additional education?
H02: There are no significant differences between the two groups in knowledge of
glaucoma.
Ha2: There are significant differences between the two groups in knowledge of
glaucoma.
RQ3: Is there an interaction effect between time and group in knowledge of
glaucoma as a function of whether patients are provided with additional education?
H03: There is no interaction effect between the time and group in knowledge of
glaucoma.
Ha3: There is an interaction effect between the time and group in knowledge of
glaucoma.
RQ4: Is patients’ (Group 1 vs. Group 2) adherence to attending a glaucoma
follow-up appointment at T3 dependent on whether patients were exposed to education
about glaucoma?
H04: The patients’ (Group 1 vs. Group 2) adherence to attending a glaucoma
follow-up appointment at T3 is not dependent on whether patients were exposed to
education about glaucoma.
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Ha4: The patients’ (Group 1 vs. Group 2) adherence to attending a glaucoma
follow-up treatment at T3 is dependent on whether patients were exposed to education
about glaucoma.
RQ5: Is patients’ (Group 1 vs. Group 2) adherence to using prescribed ocular
medication at T3 dependent on whether patients were exposed to education about
glaucoma?
H05: The patients’ (Group 1 vs. Group 2) adherence to using prescribed ocular
medication at T3 is not dependent on whether patients were exposed to education about
glaucoma.
Ha5: The patients’ (Group 1 vs. Group 2) adherence to using prescribed ocular
medication at T3 is dependent on whether patients were exposed to education about
glaucoma.
Methodology
Population Description
Participants were individuals of Russian Eastern European immigrant background
residing in New York newly diagnosed with glaucoma. Archival data underwent
examination. Excluded from the study were individuals previously diagnosed with
glaucoma or knowing that they had glaucoma yet had not received treatment. This
exclusion was necessary to reduce sample contamination and evaluate the education
provided by the patient navigator.
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Procedures for Recruitment and Participation
Data collection was by a private glaucoma clinic in New York serving the largest
Russian Eastern European immigrant population. A glaucoma specialist ophthalmologist
owns and operates the practice, seeing between 80 and 100 patients daily. Due to the
underserved nature of that area, there is a 3-month waiting list for new patients. The
practice owner performed a cost-benefit analysis of hiring and training a patient navigator
to provide education to patients and increase patient screening efficiency. The practice
collected the data during regular patient visits and new patient consultations. Using the
GKI, the patient navigator administered the educational portion of the exam in Group 2
and collected the data from both groups at T1, T2, and T3 (Celebi, 2018). After the index
administration, the patient navigator ensured good data quality by comparing the
responses to the medical records.
The glaucoma clinic provided a Data Use Agreement (see Appendix), allowing
me access to the archival dataset gathered at the facility. From this archival demographic
data, I based respondent selection on the following study inclusion criteria: (a) Russian
immigrant or of that descent, (b) age 45 to 80 years, (c) no known or diagnosed cognitive
impairment, and (d) not previously diagnosed with glaucoma. I extracted eligible
participant data from the spreadsheet, using SPSS to determine statistically significant
findings between the variables.
Data Collection
A private glaucoma clinic in New York employed and trained a patient navigator
to provide education to individuals diagnosed with glaucoma, and subsequently
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conducted a cost-benefit analysis of hiring such an individual. The data collection was
also part of the practice’s efforts to improve engagement and quality of care for its
patients. The practice administrator used a random number generator from
RANDOM.org to split the patients into two groups. Patients assigned to Group 1
underwent a standard eye exam and received a diagnosis of glaucoma and education from
a physician about their condition. Group 2 received the same exam and diagnosis as
Group 1 with additional education from a patient navigator, visual representation through
an eye model, materials in their native Russian language, and an involved demonstration
of eye drop instillation. The patient navigator spent 20 to 30 extra minutes with the
patient, allowing time for a discussion and questions. The patients were to return in 1
month for a mandatory follow-up appointment, which the clinic documented. Patients
assigned to both groups answered a GKI at three times: prior to the eye exam (T1), right
after the eye exam for Group 1 and eye exam and educational workshop for Group 2
(T2), and at their 1-month follow-up appointment (T3). The clinic sexported and
provided the data to me into Microsoft Excel.
To avoid role confusion and evaluate the cost-benefit analysis of the patient
navigator, it was necessary to specify roles. After signing in for their visit, a practice
assistant escorted Group 1 patients into a screening room and administered the GKI
questionnaire (T1), with responses collected via pen and paper. The patients then
received the usual workup consisting of chief complaint, medication verification, and
best corrected visual acuity measure. The ophthalmologist then met with the patients to
conduct a standard slit lamp exam and pressure check and discuss the findings. The
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ophthalmologist presented the ocular medications and requested a follow-up appointment
in 1 month to ensure the drops controlled the pressure. This prescreening and the exam
took approximately 15 minutes. At the conclusion of this exam, the practice assistant
administered the GKI (T2). The patient then scheduled a 1-month follow-up appointment
with the front desk receptionist. At the follow-up appointment, the practice assistant
administered the GKI during the screening (T3) prior to the medical exam by the
ophthalmologist. If patients missed their follow-up exam, the clinic made one
rescheduling attempt. If the attempt was unsuccessful or the patient did not show up to
the rescheduled appointment, I treated the participant’s information as missing data.
Patients assigned to Group 2 received the same care as those in Group 1.
However, after the ophthalmologist exam, Group 2 patients went into the patient
navigator’s office, where they received education about their diagnosis with the aid of a
visual model of the eye. The patient navigator also provided a handout describing
glaucoma and what occurs without following proper treatment. The patient navigator also
demonstrated the proper instillation of ocular drops and had the patient practice with the
eye model. The take-home materials were available in English and in Russian. After the
exam, the patient navigator escorted the patient to the front desk to schedule a 1-month
follow-up appointment. Prior to the patient leaving the practice, the assistant
administered the GKI (T2). At the 1-month follow-up appointment, the practice assistant
administered the GKI during the screening (T3), prior to the medical exam by the
ophthalmologist. For patients who missed their follow-up exam, there was one attempt at
rescheduling the appointment, at which time (T3) they completed the questionnaire. If the
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office could not reach the patient or the patient did not attend the rescheduled
appointment, the participant’s responses had missing data and were not entered into the
calculations.
Sampling and Sampling Procedure
The data set came from a private glaucoma clinic in New York. I conducted a
G*Power analysis to calculate the minimum sample size required to detect an effect. To
detect a medium effect size of partial eta-squared of 0.1 with 80% power, an industryrecommended minimum for between-subjects repeated measures, the G*Power analysis
showed a need for 82 participants in each group for a total sample size of 164. This was a
calculation for ANOVA, with equal sample sizes for each group (see Bakeman, 2005;
Lakens, 2013). To account for an estimated 25% attrition from T1/T2 for the data
gathered on the same day as T3, collected at the 1-month follow-up appointment, I used
data from 206 participants at T1/T2 (103 from Group 1 and 103 from Group 2). Results
from the power analysis are shown in Figure 2.
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Figure 2
Results From Power Analysis

Note. Minimum sample size.
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Instrumentation and Operationalization of Constructs
Celebi (2018) developed the GKI to assess patients’ knowledge about glaucoma.
Celebi used the GKI in a research hospital in Istanbul, Turkey, to assess knowledge and
awareness of glaucoma in subjects with glaucoma and their first-degree relatives.
Because the GKI is an index of knowledge, reliability is irrelevant; therefore, there was
no need to compute a Cronbach’s alpha (see Bland & Altman, 2002). The scale for this
design was across nine questions in the analysis, including an aggregate of true-false and
multiple-choice answers. I created a total score of knowledge, reporting the means and
standard deviation after data analysis.
The IV in this study was education about glaucoma provided by a patient
navigator. The IV was a dichotomous variable with two levels: two groups of patients.
Patients in Group 1 received usual and standard care provided by an ophthalmologist
during an initial visit; Group 2 patients received the same care as Group 1 with additional
education provided by a patient navigator. After the patients’ standard visit and a
discussion with an ophthalmologist, the patient navigator spent 20 to 30 minutes
providing education about glaucoma through a visual representation of an eye model and
take-home materials in their native Russian language. In addition, the patient navigator
conducted an involved demonstration of proper eye drop instillation. Changes in
knowledge about glaucoma, one of the DVs, was the construct I examined in this study.
Operationalizing knowledge changes was by participants’ responses to the GKI, a nineitem index with each question worth 1 point. The questions were means to determine
whether the individuals had knowledge and understanding of glaucoma, its predisposing
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factors, and treatment. Determining patients’ understanding and knowledge about
glaucoma was by calculating the number of points scored by the individual on the GKI,
with the scores ranging from 0 to 9. For this study, individuals having a high level of
knowledge and understanding about glaucoma (e.g., GKI scores of 8 or 9) were
considered knowledgeable about glaucoma; individuals with low levels of adherence
(GKI scores of 7 or lower) were considered not knowledgeable. I considered changes in
knowledge about glaucoma as a function of time.
The next DV was adherence to follow-up care, a dichotomous variable measured
by whether patients attended their scheduled follow-up appointments. Another DV was
adherence to ocular medication utilization, which was also a dichotomous variable
measured by whether patients used their prescribed ocular medications. Measurement of
this variable was by patient self-report.
Data Analysis Plan
I used SPSS to process and analyze the quantitative data. This program also
allowed data cleaning and screening. Data processing techniques consisted of identifying
potential outliers and testing the assumptions of each statistical analysis.
The first three research questions (RQ1, RQ2, and RQ3) required examining the
extent to which patients’ exposure to education about glaucoma through a patient
navigator impacted their knowledge about glaucoma, as measured before and after the
eye exam. The glaucoma education provided by the patient navigator was the IV, and the
patients’ knowledge of glaucoma was the DV. The IV had two categories: group
membership (i.e., whether the participants were in Group 1 or Group 2) and time of
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assessment (i.e., T1, T2, or T3). The DV, a continuous measure, was the knowledge
about glaucoma. The statistical analysis used to answer this research question was a
repeated measures ANOVA.
The DV was continuous to determine variability, giving it prediction power. I was
looking for three effects: within subjects (pretest vs. posttest scores), between subjects
(Group 1 vs. Group 2), and whether there was an interaction effect. If the interaction
effect was significant, the main effects of time and grouping required investigation. An
interaction between the two IVs provides an understanding of whether knowledge
changes over time differently depending on group membership.
One assumption for a repeated measures ANOVA is normality, with the DV and
within-subjects IV normally distributed. Violating this assumption allows for the use of
transformation. Another assumption was sphericity, where the variance of the difference
scores for any two levels of the within-subjects IV was similar to the variance of the
difference scores for any other two levels of the within-subjects IV. Mauchly’s test of
sphericity was a means to test this assumption, with a violation meriting the use of p <
.05 and the Greenhouse-Geisser or Huynh-Feldt corrections. Another assumption was
that of homogeneity of variance, where the standard deviation of the DV should be equal
between the two groups. Testing the equality of variances entailed performing Levene’s
test. If p < .05, the Welch-Satterthwaite method is a way to make adjustments based on
the degrees of freedom.
RQ4 pertained to how exposure to education about glaucoma predicts patients’
adherence to follow-up treatment at T3. The IV, group membership, underwent analysis
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as a categorical variable with two levels, Group 1 and Group 2. The DV, whether patients
showed up to the T3 appointment, was a categorical variable analyzed as a follow-up
appointment attended or missed. Because of the categorical nature of the IV and DV, a
chi-square test of independence was appropriate.
The fifth research question (RQ5) was specific to how exposure to education
about glaucoma predicts patients’ adherence to the use of prescribed ocular medications.
The IV was group membership (Group 1 vs. Group 2), with the study groups independent
and analyzed as a categorical variable with two levels. The DV, whether they used their
prescribed ocular medications as instructed by the physician, was also a categorical
variable analyzed as medication used or not used.
The chi-square test of independence was appropriate to address the fourth and
fifth research questions because it is a nonparametric test designed to analyze whether
there is a significant relationship between two categorical variables (McHugh, 2013;
Montgomery, 2013). This statistical analysis was suitable because group status and the
DVs (attendance at the follow-up and taking medication) are dichotomous variables. The
chi-square test is nonparametic and does not assume a normal distribution, making it
appropriate for dichotomous variables. The statistical analysis was a means to test for the
relationship of group status to follow-up attendance by examining whether the
distribution of yes and no in Group 1 matched the distribution of yes and no in Group 2.
This kind of analysis was limited to variables in which both levels were mutually
independent, such that no participant fell into both Group 1 and Group 2. The chi-square
test allows for examining data at a single time point only rather than in a longitudinal
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fashion (McHugh, 2013). Additionally, the chi-square test is sensitive to sample size.
This statistical analysis is appropriate to determine whether a relationship exists between
two variables; it cannot test for a causal effect from one variable to the other (McHugh,
2013).
Threats to Validity
Threats to Internal Validity
Potential threats to internal validity included whether there was enough variation
in the DV and the ability to index the degree of difference among people’s glaucoma
knowledge. Another threat to internal validity could have been having more patients than
normal attend their follow-up visit (T3) due to the severity of their glaucoma symptoms,
something not assessed. Last, prior to agreeing to participate in the study, patients learned
that if assigned to Group 2, they might have to spend up to an extra 30 minutes with a
patient navigator. If patients opted not to participate due to the requirement of extra time,
there could be a difference in conscientiousness between the groups, which could have
been an unstudied third variable.
Threats to External Validity
One threat to external validity was the lack of transferability. The population
assessed was Russian Eastern European immigrants in New York. Because the results
apply to a narrow population and a specific situation, the findings might have poor
generalizability. Another potential threat to external validity was selection bias. Because
patients self-selected to participate in this study, there could have been volunteer bias,
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with individuals who volunteer to participate in a research project different in some ways
from the general population.
Ethical Procedures
Agreement to Gain Access to Data
A private glaucoma clinic located in New York provided a Data Use Agreement
(see Appendix), allowing me access to the archival data collected at its facility. The
practice deidentified the archived data before it was available. Upon receipt of the Excel
file, I extracted information relevant to the study. Subsequently, I coded data to eliminate
patient identifiers and limit the risk of exposure. I did not receive or analyze data until
receiving written approval from Walden University’s Institutional Review Board (IRB;
Approval No. 08-31-20-0725508).
Treatment of Archival Data
The archived data remain safeguarded to prevent unwanted access. I was ethically
obligated to ensure that the use of data and dissemination of findings would not harm the
system that provided the data or to the people who accessed the health care system.
Therefore, the use of archived data was solely for this study. The data obtained are not
available to any other person or organization. I did not need to obtain patients’ informed
consent, as I analyzed only archival data. No treatment or invasive tests occurred during
or for this study. I will maintain the deidentified archival data on a password-protected
external flash drive for 5 years, after which I will destroy all files.
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Summary
Chapter 3 presented the study design, sample characteristics and sampling
methods, instrumentation, data analysis, and ethical procedures. Data collection was by a
private glaucoma clinic in New York, which provided a Data Use Agreement. Upon
obtaining IRB approval, I conducted a longitudinal retrospective study using the obtained
archival data. There was no need to contact patients for the study.
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Chapter 4: Results
The purpose of this study was to explore whether additional education about
glaucoma has an effect on patient knowledge of glaucoma, patient adherence to ocular
medication use, and follow-up appointment attendance. The general question that guided
this research was the following: Does the independent variable (exposure to education
about glaucoma through a patient navigator) have an effect on patient knowledge of
glaucoma, patient adherence to follow-up visits, and patient utilization of prescribed
ocular medications among patients newly diagnosed with glaucoma among the Russian
Eastern European immigrant population in a private glaucoma specialty clinic in New
York? I investigated this general question through five specific RQs:
RQ1: Are there significant differences between pretest and posttest in knowledge
of glaucoma as a function of whether patients are provided with additional education?
H01: There are no significant differences between pretest and posttest in
knowledge of glaucoma.
Ha1: There are significant differences between pretest and posttest in knowledge
of glaucoma.
RQ2: Are there significant differences between the two groups in knowledge of
glaucoma as a function of whether patients are provided with additional education?
H02: There are no significant differences between the two groups in knowledge of
glaucoma.
Ha2: There are significant differences between the two groups in knowledge of
glaucoma.
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RQ3: Is there an interaction effect between time and group in knowledge of
glaucoma as a function of whether patients are provided with additional education?
H03: There is no interaction effect between the time and group in knowledge of
glaucoma.
Ha3: There is an interaction effect between the time and group in knowledge of
glaucoma.
RQ4: Is patients’ (Group 1 vs. Group 2) adherence to attending a glaucoma
follow-up appointment at T3 dependent on whether patients were exposed to education
about glaucoma?
H04: The patients’ (Group 1 vs. Group 2) adherence to attending a glaucoma
follow-up appointment at T3 is not dependent on whether patients were exposed to
education about glaucoma.
Ha4: The patients’ (Group 1 vs. Group 2) adherence to attending a glaucoma
follow-up treatment at T3 is dependent on whether patients were exposed to education
about glaucoma.
RQ5: Is patients’ (Group 1 vs. Group 2) adherence to using prescribed ocular
medication at T3 dependent on whether patients were exposed to education about
glaucoma?
H05: The patients’ (Group 1 vs. Group 2) adherence to using prescribed ocular
medication at T3 is not dependent on whether patients were exposed to education about
glaucoma.

72
Ha5: The patients’ (Group 1 vs. Group 2) adherence to using prescribed ocular
medication at T3 is dependent on whether patients were exposed to education about
glaucoma.
In this chapter, I present the collected archived data and include information
regarding the procedures for gathering the patients’ information. Analysis of data to
answer the first three RQs (examining the extent to which patients’ exposure to education
about glaucoma through a patient navigator impacts their knowledge about glaucoma)
entailed using a repeated measures ANOVA. Answering the fourth and fifth RQs entailed
conducting a chi-square test of independence.
Data Collection
I obtained the study data from a private glaucoma clinic located in Kings County
of New York, which had conducted a cost-benefit analysis for hiring a patient navigator.
The data collection was also part of the practice’s efforts to improve the engagement and
quality of care for the patients. The clinic administered the GKI (Celebi, 2018) to 206
patients at three time points (T1, T2, and T3) between December 2018 and December
2019. The patient navigator was responsible for administering the GKI and providing
education to Group 2 patients. The clinic had adequately trained and certified the patient
navigator before assigning them to the patients. The patient navigator had been an
ophthalmic technician for 17 years before transitioning to the role. The patient navigator
was a native Russian speaker able to communicate with patients in either English or
Russian, as they preferred.
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Results
Preparing Data for Analysis
Data cleaning is a significant component of preparing data for analysis. Upon
receipt of the archival data in an Excel spreadsheet, I recoded the numerical answers for
the 11 questions. Some questions were multiple choice and allowed for more than one
answer; some of the answers given included correct and incorrect responses. For this
analysis, if a patient had selected both a correct and an incorrect answer choice, I counted
the response as correct, giving the participant full credit. Recoded responses for
Questions 3 through 11 were 0 = incorrect and 1 = correct. Questions 1 and 2 remained
the same because they were part of demographic knowledge gathering. After removing
all personal identifiers from the data set, I converted the Excel spreadsheet into an SPSS
data file to record responses in a numerical format.
Descriptive Statistics
The IV for this study was whether participants received education about glaucoma
from a patient navigator. The DVs included patient knowledge about glaucoma,
attendance of follow-up appointments, and adherence to using prescribed ocular
medications. Tables 1 and 2 present a summary of the descriptive variables for each
variable included in the data analysis.
There were 206 participants evenly split between Group 1 (control; n = 103) and
Group 2 (intervention; n = 103). Table 1 shows the sample descriptive statistics for the
categorical variables of attendance of follow-up appointments and adherence to using
prescribed ocular medications for the entire sample and then separated by group. Of the
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206 participants, 70.4% attended the follow-up (n = 145). Most of these patients reported
medication adherence (n = 111; 53.9%), as shown in Table 1. For those in Group 1, 67
attended the follow-up (65%), of whom 47 adhered to medication (70.1%). In Group 2,
78 participants attended the follow-up (75.7%), of whom 64 adhered to medication
(82.1%).
Table 1
Frequencies of Demographic Variables
Variable
Condition
Control
Intervention
Total
Attend 3 months
No
Yes
Total
Medication
Did not adhere
Adhered
Total

Entire sample
Frequency
%

Control
Frequency
%

Intervention
Frequency
%

103
103
206

50.0
50.0
100.0

61
145
206

29.6
70.4
100.0

36
67
103

35.0
65.0
100.0

25
78
103

24.3
75.7
100.0

34
111
145

23.4
76.6
100.0

20
47
67

29.9
70.1
100.0

14
64
78

17.9
82.1
100.0

Table 2 presents descriptive statistics for GKI at all three time points (T1, T2, and
T3) for the entire sample, and then separated by group. Across the sample, the mean GKI
score at T1 was 4.28, with a standard deviation of 1.81. The mean GKI score at T2 was
8.08, with a standard deviation of 2.06; at T3, the mean was 7.63, with a standard
deviation of 1.99.
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Table 2
Descriptives for Continuous GKI at All Three Time Points
Variable
Entire sample
GKI T1
GKI T2
GKI T3
Control
GKI T1
GKI T2
GKI T3
Intervention
GKI T1
GKI T2
GKI T3

N

Min

Max

Mean

Std.
Dev

Skew

Kurtosis

Stat

SE

Stat

SE

206
206
145

2
2
2

9
10
10

4.28
8.08
7.63

1.81
2.06
1.99

0.71
-0.84
-0.60

0.17
0.17
0.20

-0.06
-0.32
-0.49

0.34
0.34
0.40

103
103
67

2
2
2

9
10
10

4.61
6.60
6.22

1.98
1.82
1.79

0.55
-0.16
0.06

0.24
0.24
0.29

-0.46
-0.19
-0.12

0.47
0.47
0.58

103
103
78

2
4
5

9
10
10

3.95
9.56
8.85

1.57
0.90
1.20

0.74
-3.64
-1.14

0.24
0.24
0.27

0.20
17.12
0.95

0.47
0.47
0.54

Testing Statistical Assumptions
Testing the statistical assumptions of the first three RQs was by using a repeated
measures ANOVA. The first assumption of a repeated measures ANOVA is that DV
measurement was continuous. Because I measured patient knowledge about glaucoma
continuously, this assumption was met.
Examining the second assumption of normality of the DV occurred in three ways.
First, I performed the Shapiro-Wilk’s test to determine whether glaucoma knowledge was
normally distributed at all three time points. I found this not to be the case (p < .05), as
shown in Table 3. Next performed was a visual inspection of the histograms of glaucoma
knowledge at all three time points (see Figures 3–5). The visual inspection showed that
the distribution of glaucoma knowledge at T1 and T3 did not indicate a large departure
from a normal distribution. However, the distribution of glaucoma knowledge at T2
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showed a heavy amount of skew. Finally, I examined skewness and kurtosis at all three
time points for the entire sample as well as separated by group, as shown in Table 2. In
concurrence with the visual inspection, skewness and kurtosis fell within the acceptable
+/-1 range, except for glaucoma knowledge at T2 for the intervention group. Figure 6
shows that the extreme level of skewness at T2 for the intervention group was due to
most of Group 2 reporting high scores on glaucoma knowledge after receiving additional
education. A square root transformation of each time point was necessary due to the
extreme nature of skewness at T2. However, using the transformed version of GKI did
not change the results of the repeated measures ANOVA. I kept the original version of
the DV at all three time points to ease findings interpretation.
Testing the final assumption of homogeneity of sphericity was by using
Mauchly’s test of sphericity to examine whether the variance in glaucoma knowledge
was equal for all possible pairs. Mauchly’s test indicated a violation of the assumption of
sphericity for the two-way interaction (χ2(2) = 43.74, p < .001, ε = 0.79). Because the
estimated epsilon was over 0.75, the Huynh-Feldt correction was necessary to examine
the interaction between GKI time and group (see Collier et al., 1967).
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Table 3
GKI Pairwise Comparisons Between Time Points
Variable
GKI T1
T2
T3
GKI T2
T1
T3
GKI T3
T1
T2

Mean difference

SE

p

-3.86*
-3.23*

0.14
0.14

< .001
< .001

3.86*
.64*

0.14
0.09

< .001
< .001

3.23*
-.64*

0.14
0.09

< .001
< .001

Figure 3
Histogram of GKI at Time 1 for the Entire Sample
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Figure 4
Histogram of GKI at Time 2 for the Entire Sample

Figure 5
Histogram of GKI at Time 3 for the Entire Sample
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Figure 6
Histograms of Glaucoma Knowledge by Time and Group
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Glaucoma Knowledge
I conducted a repeated measures ANOVA to examine the first three research
questions. The model had a within-subjects variable of time when the clinic gathered
glaucoma knowledge (T1, T2, and T3). The between-subjects variable was group, which
contained two levels: Group 1 and Group 2. The model also incorporated the interaction
between time and group.
RQ1: Are there significant differences between pretest and posttest in knowledge
of glaucoma as a function of whether patients are provided with additional education?
H01: There are no significant differences between pretest and posttest in
knowledge of glaucoma.
Ha1: There are significant differences between pretest and posttest in knowledge
of glaucoma.
To determine whether glaucoma knowledge differed between time points, I
examined the main effect of time in the repeated measures ANOVA. There was a
statistically significant main effect of time point, such that glaucoma knowledge was
significantly different between at least two time points (F(2, 286) = 541.40, p < .001,
partial η2 = .79). Pairwise dependent t tests indicated that all comparisons between time
points were statistically significant, as shown in Table 4.
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Table 4
GKI Estimated Marginal Means by Group for All Time Points
Variable
GKI T1
Control
Intervention
GKI T2
Control
Intervention
GKI T3
Control
Intervention

M

SE

95% CI

4.61
3.95

0.18
0.18

[4.27, 4.96]
[3.61, 4.30]

6.60
9.56

0.14
0.14

[6.32, 6.88]
[9.28, 9.84]

6.22
8.85

0.18
0.17

[5.86, 6.59]
[8.51, 9.18]

RQ2: Are there significant differences between the two groups in knowledge of
glaucoma as a function of whether patients are provided with additional education?
H02: There are no significant differences between the two groups in knowledge of
glaucoma.
Ha2: There are significant differences between the two groups in knowledge of
glaucoma.
For this research question, I examined the main effect of group from the repeated
measures ANOVA, where group was the between-subjects variable. There was a
statistically significant main effect of group, such that Group 1 (M = 5.73, SD = 1.67)
overall had lower glaucoma knowledge than Group 2 (M = 7.27, SD = 0.97; F(1, 143) =
56.13, p < .001, partial η2 = .28).
RQ3: Is there an interaction effect between time and group in knowledge of
glaucoma as a function of whether patients are provided with additional education?
H03: There is no interaction effect between the time and group in knowledge of
glaucoma.
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Ha3: There is an interaction effect between the time and group in knowledge of
glaucoma.
To answer RQ3, I examined the interaction from the repeated measures ANOVA
between the within-subjects variable of GKI timepoint and the between-subjects variable
of Group. The Huynh-Feldt correction was the means to account for the violation of
sphericity. The interaction was significant even with the correction, indicating differences
between the groups for at least one time point (F(1.61, 229.77) = 134.01, p < .001, partial
η2 = .48). Table 4 shows the breakdown of estimated marginal means and standard errors
for condition by each time point. To decompose the interaction, I conducted a simple
main effect of group at all three time points.
Figure 7 presents the baseline glaucoma knowledge at T1 for both groups.
Glaucoma knowledge at T1 was statistically significantly greater in Group 1 compared to
Group 2 (F(1, 204) = 7.05, p < .01, partial η2 = .03). This difference indicates that despite
participants’ random assignment, the control condition had a slightly higher baseline.
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Figure 7
Means for Glaucoma Knowledge at Time 1 by Group

Glaucoma Index Knowledge T1

6

**

5
4
3
2
1
0
G1 - Control

G2 - Intervention

Condition

Note. Error bars indicate standard error of the means; ** indicates p < .01.
Figure 8 shows glaucoma knowledge gathered from both groups (intervention and
control) at T2. The collection of this time point was on the same day as T1, immediately
after the eye exam for the control group and after the exam and additional education
about glaucoma provided by the patient navigator for the intervention group. At T2,
glaucoma knowledge was significantly higher for the intervention group compared to the
control group (F(1, 204) = 219.33, p < .001, partial η2 = .52; see Figure 8).
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Figure 8
Means for Glaucoma Knowledge at Time 2 by Group

Glaucoma Index Knowledge T2
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***
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G2 - Intervention
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Note. Error bars indicate standard error of the means; *** indicates p < .001.
Figure 9 illustrates means for glaucoma knowledge at T3, as collected for all
patients at the 1-month follow-up appointment. At T3, the intervention group still
demonstrated significantly higher knowledge of glaucoma (F(1, 143) = 110.13, p < .001,
partial η2 = .44. This difference indicates that patients in the intervention group retained
the increased knowledge about glaucoma at a 1-month follow-up appointment.
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Figure 9
Means for Glaucoma Knowledge at Time 3 by Group
***
Glaucoma Index Knowledge T3
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Note. Error bars indicate standard error of the means; *** indicates p < .001.
Figure 10 is a summary of the GKI results at T1, T2, and T3. The figure shows
that at baseline (T1), the control group (Group 1) had greater glaucoma knowledge than
the intervention group (Group 2). T2, conducted on the same day as T1, indicates a jump
in knowledge for both groups, with the intervention group having a greater overall
increase in knowledge. The figure also shows that at a 1-month follow-up appointment,
there was a slight decrease in knowledge in both groups from T2, with the intervention
group maintaining a general trend increase in knowledge from the T1 baseline.
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Figure 10
Glaucoma Knowledge Index at Time 2 and Time 3 by Group

Glaucoma Knowledge Index
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Note. Error bars indicate standard error of the means; ** indicates p < .01; *** indicates p
< .001.
Figure 11 presents the full interaction with marginal means for conditions by each
time point. The interaction shows that at T1, the control condition scored higher on the
GKI than the intervention. At T2, the intervention condition scored significantly higher
on the GKI, and at T3, both conditions dropped while maintaining the differential
between the control and intervention conditions, with the intervention scoring higher.
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Figure 11
Marginal Means Interaction
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Note. The interaction effect.
RQ4: Is patients’ (Group 1 vs. Group 2) adherence to attending a glaucoma
follow-up appointment at T3 dependent on whether patients were exposed to education
about glaucoma?
H04: The patients’ (Group 1 vs. Group 2) adherence to attending a glaucoma
follow-up appointment at T3 is not dependent on whether patients were exposed to
education about glaucoma.
Ha4: The patients’ (Group 1 vs. Group 2) adherence to attending a glaucoma
follow-up treatment at T3 is dependent on whether patients were exposed to education
about glaucoma.
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To answer RQ4, I performed a chi-square test of independence between the
variables of group and attendance at the follow-up visit (T3). There was no difference
between Group 2 and Group 1 attendance for the follow-up glaucoma exam. Marginally,
more participants in Group 2 attended the 3-month follow-up visit compared to
participants in Group 1 (χ2 (1) = 2.82, p = .09, V = .12). This was apparent by the p = .09,
which was larger than the accepted cut-off value of α = .05, making the results not
statistically significant (Cohen, 1988).
Table 5 shows the frequency breakdown by group of those who did and did not
attend the follow-up. The effect size (Cramer’s V) for group’s relationship to follow-up
attendance was small. According to Cohen (1988), Cramer’s V values of .1 to .3 are
considered to have a small effect size. Therefore, this study’s Cramer’s V value of .12
indicates the assumption of no relationship between variables of education about
glaucoma provided by a patient navigator and patient’s adherence to attending a
glaucoma follow-up appointment.
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Table 5
Chi-Square Cell Breakdown for Time 3 Follow-Up Attendance by Group
Group
Group 1
Count
% within Group
% within Attend
% of Total
Group 2
Count
% within Group
% within Attend
% of Total
Total
Count
% within Group
% within Attend
% of Total

Attended follow-up
Did not attend
Attended

Total

36
35.00%
59.00%
17.50%

67
65.00%
46.20%
32.50%

103
100.00%
50.00%
50.00%

25
24.30%
41.00%
12.10%

78
75.70%
53.80%
37.90%

103
100.00%
50.00%
50.00%

61
29.60%
100.00%
29.60%

145
70.40%
100.00%
70.40%

206
100.00%
100.00%
100.00%

RQ5: Is patients’ (Group 1 vs. Group 2) adherence to using prescribed ocular
medication at T3 dependent on whether patients were exposed to education about
glaucoma?
H05: The patients’ (Group 1 vs. Group 2) adherence to using prescribed ocular
medication at T3 is not dependent on whether patients were exposed to education about
glaucoma.
Ha5: The patients’ (Group 1 vs. Group 2) adherence to using prescribed ocular
medication at T3 is dependent on whether patients were exposed to education about
glaucoma.
To answer RQ5, I performed a chi-square test of independence between the
variables of group and medication adherence reported at the follow-up visit (T3).
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Marginally, more participants in Group 2 reported adhering to medication at T3
compared to participants in Group 1 (χ2(1) = 2.84, p = .09, V = .14). Table 6 shows the
frequency breakdown of those who did and those who did not adhere to medication by
Group. The p = .09 was below the accepted convectional industry standard of p < .05,
making the results not statically significant.
The effect size (Cramer’s V) for group’s relationship to adherence to using
prescribed ocular medication was small. According to Cohen (1988), Cramer’s V values
of .1 to .3 are considered to have a small effect size. Therefore, a Cramer’s V value of .14
in this study indicates the assumption of no relationship between variables of education
about glaucoma provided by a patient navigator and patient adherence to using prescribed
ocular medication.
Table 6
Chi-Square Cell Breakdown for Medication by Group
Group
Group 1
Count
% within Group
% within Attend
% of Total
Group 2
Count
% within Group
% within Attend
% of Total
Total
Count
% within Group
% within Attend
% of Total

Medication
Did not adhere
Adhered

Total

20
29.90%
58.80%
13.80%

47
70.10%
42.30%
32.40%

67
100.00%
46.20%
46.20%

14
17.90%
41.20%
9.70%

64
82.10%
57.70%
44.10%

78
100.00%
53.80%
53.80%

34
23.40%
100.00%
23.40%

111
76.60%
100.00%
76.60%

145
100.00%
100.00%
100.00%
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Summary
The IV was exposure to education about glaucoma through a patient navigator;
the DVs were patient knowledge of glaucoma, patient adherence to follow-up visits, and
patient utilization of prescribed ocular medications. Overall, patient knowledge of
glaucoma at pretest differed from knowledge at posttest. There was a statistically
significant main effect of the IV (education about glaucoma through a patient navigator)
such that the overall intervention group had higher glaucoma knowledge than the control
group. Additionally, there was a statistically significant interaction between the IV
(education about glaucoma through a patient navigator) and the time of glaucoma
knowledge assessment, indicating that the IV effect differed depending on the time point
of assessing glaucoma knowledge. For example, Group 1 reported more glaucoma
knowledge at pretest compared to Group 2, whereas Group 2 reported higher glaucoma
knowledge at both posttest time points. These results indicate a rejection of the null
hypotheses for RQ1, RQ2, and RQ3.
RQ4 pertained to examining whether patients’ adherence to attending a glaucoma
follow-up appointment at T3 was dependent on their exposure to education about
glaucoma. The results indicate an inability to reject the null hypothesis, which suggests
that there is no statistically significant relationship between the IV (education about
glaucoma through a patient navigator) and the DV (patients’ adherence to attending a
glaucoma follow-up appointment). Patient adherence to follow-up visits was not
dependent on education about glaucoma provided through a patient navigator.
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RQ5 was specific to examining whether patients’ adherence to using prescribed
ocular medication at T3 was dependent on the presence or absence of exposure to
education about glaucoma. From the results, it was not possible to reject the null
hypothesis, suggesting that there was no statistically significant relationship between the
IV (education about glaucoma through a patient navigator) and the DV (patients’
adherence to using prescribed ocular medication). Patient utilization of prescribed ocular
medications was not dependent on education about glaucoma provided through a patient
navigator.
Chapter 5 presents a detailed interpretation of the findings within the limits and
scope of the study. I also discuss the study’s limitations and the implications for social
change. Following a description of the methodological, theoretical, and empirical
implications of this study are recommendations and a conclusion.
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Chapter 5: Discussion, Conclusions, and Recommendations
In this study, I sought to determine whether education about glaucoma provided
by a patient navigator had an effect on patient knowledge about glaucoma as well as
patient adherence to follow-up visits and medication utilization among Russian Eastern
European immigrant patients. I used a longitudinal design, incorporating archival data
from a private glaucoma clinic located in New York. Quantitative research methods were
appropriate to determine whether there were significant differences between the two
groups in their knowledge of glaucoma pretest versus posttest as well as whether there
was an interaction effect between time and group. Additionally, the quantitative approach
allowed me to determine whether adherence to attending follow-up appointments or
using prescribed ocular medications were dependent on exposure to education about
glaucoma. This chapter includes an interpretation of the findings, discussion of
limitations encountered, recommendations for research, and implications for social
change resulting from this study.
Interpretation of Findings
After receiving Walden University’s IRB approval, I obtained deidentified patient
data from a private glaucoma clinic in New York. The practice had run a cost-benefit
analysis of hiring and training a patient navigator to provide education to patients and
increase the efficiency of patient screening. The clinic collected the data during
established patients’ regular visits and new patient consultations. The clinic provided me
with 206 patient records that met the inclusion criteria of (a) Russian immigrant or of that
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descent, (b) age 45 to 80 years, (c) no known or diagnosed cognitive impairment, and (d)
and not diagnosed with glaucoma in the past.
The practice collected, stored, and archived data and subsequently provided them
to me in an Excel spreadsheet. I conducted the data analyses for this study using SPSS.
Analyses of the first three research questions were executed by using a repeated measures
ANOVA, with the fourth and fifth research questions analyzed using a chi-square test of
independence. In the next section, I discuss the results of these statistical tests in relation
to the current literature and the study’s research questions.
Improvement of Glaucoma Knowledge
Data analysis indicated a significant difference between Group 1 and Group 2 at
different time points of GKI assessment. Glaucoma knowledge at T1 was statistically
significantly greater in Group 1 compared to Group 2 (F(1, 204) = 7.05, p < .01, partial
η2 = .03). This difference indicates that although participants received random group
assignment, the control group had a slightly higher baseline GKI knowledge score than
the intervention group. At T2, glaucoma knowledge was significantly higher for the
intervention group compared to the control group (F(1, 204) = 219.33, p < .001, partial η2
= .52). The clinic administered the GKI assessment at this time point immediately after
the eye exam for the control group, and after the exam and additional education about
glaucoma provided by the patient navigator for the intervention group. At T3, all patients
completed the GKI to gauge their glaucoma knowledge at their 1-month follow-up
appointment. The intervention group still demonstrated significantly higher knowledge of
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glaucoma (F(1, 143) = 110.13, p < .001, partial η2 = .44), indicating they retained the
increased knowledge about glaucoma at a 1-month follow-up appointment.
Data analysis showed that educational intervention provided by a patient
navigator had improved patients’ knowledge about glaucoma, with lasting effects into
their 1-month follow-up eye appointment. Results from prior studies supported these
findings, showing that glaucoma education delivered in person through individualized
counseling was more effective in improving overall glaucoma knowledge in newly
diagnosed patients than giving patients take-home materials or brochures or having them
watch videos (McVeigh & Vakros, 2015; Newman-Casey et al., 2015; Okeke et al.,
2009). Gray et al. (2012) randomized 127 newly diagnosed glaucoma patients to a
personalized, individual health care assessment in addition to standard care or standard
care with an ophthalmologist. Gray et al.’s intervention began with a 75-minute
counseling session with a glaucoma nurse to design a 1-year personalized follow-up plan.
This longitudinal study assessed patient knowledge over 1 year and included five
appointments with the nurse throughout the year, each lasting 15 to 30 minutes, to further
educate patients or answer questions. Intervention arm patients had a significantly greater
knowledge of glaucoma (p < .001) at the end of the study than the control arm. Although
the intervention proved efficacious when it came to knowledge retention for glaucoma
patients, the cost-effectiveness of hiring a nurse to spend this time with patients proved
detrimental to the practice’s financial sustainability. Gray et al. suggested finding lessinvolved educational interventions that might not require a full-time nursing position.
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Building on Gray et al.’s findings, Cate et al. (2014) evaluated a behavior change
counseling program for 208 newly diagnosed glaucoma patients. The counseling included
glaucoma education and motivational support from trained paraprofessional staff called
glaucoma support assistants. Paraprofessional staff attended 7 hours of training about
glaucoma and its treatment, barriers to adherence, and brief motivational interviewing
techniques. Patients’ sessions with glaucoma support assistants lasted between 15 and 60
minutes. There was no statistically significant difference in the proportion of individuals
with ≥ 80% glaucoma knowledge scores, with 62.5% in the control group and 66.7% in
the intervention group (p = 0.63). Cate et al. stated that despite finding no additional
increase in patient education about glaucoma, inexpensively providing information
tailored to the individual resulted in high patient satisfaction with retaining information
about glaucoma.
I evaluated an intervention that was cost-effective and did not warrant a separate
clinical position to provide educational support to newly diagnosed patients. The
intervention might have been successful due to the provision of education by a navigator,
who was a trained optician for many years before shifting into navigating. Last, this
intervention might have been successful because of the cultural similarity between the
navigator and the patient population, thereby creating a sense of implicit alliance.
Adherence to Follow-Up Eye Appointments
Data analysis for evaluating adherence to attending a glaucoma follow-up
appointment at T3 indicated no statistically significant difference in Group 1 versus
Group 2. Marginally, more participants in Group 2 attended the 3-month follow-up visit
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(p = .09) compared to Group 1 participants. The literature has shown compliance and
adherence to attending follow-up eye exam appointments as concerns in glaucoma
treatment (Davis et al., 2018; Johnson et al., 2016; C. X. Zheng et al., 2016). The low
follow-up rate among newly diagnosed glaucoma patients suggests there could be
significant barriers affecting follow-up adherence after receiving an ocular diagnosis
(Newman-Casey, Robin, et al., 2015). Initially, Newman-Casey, Robin, et al. (2015) cited
a lack of education and patients’ misunderstanding their diagnosis as barriers to attending
follow-up eye appointments.
Building on Newman-Casey, Robin, et al.’s (2015) findings, other researchers
evaluated adherence to follow-up appointment rates with the implementation of an
educational component into the diagnosis. Hark et al. (2019) found that despite various
educational interventions, adherence to follow-up appointments was still lacking. Hark et
al. noted that cultural, racial, and linguistic barriers between health care providers and
patients significantly affected the quality of health care delivery, ability to access health
care, and poor health outcomes. Hark et al. evaluated 535 participants, with 172
randomized to the intervention group and connected with a social worker who provided
reminder phone calls and transportation assistance to the follow-up appointments. Even
with the social worker intervention, there was no statistically significant difference
between the control and intervention groups in adherence to follow-up appointments.
These results parallel other studies, which have shown forgetfulness and lack of
education about the importance of attending follow-up eye exam appointments to be the
most commonly cited reasons for missed eye exam visits (Murchison et al., 2017). Hark
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et al. (2019) suggested using a culturally competent patient navigator as an educational
and supportive component of patients’ treatment. Based on these recommendations, I
attempted to evaluate such a service delivery through a culturally competent patient
navigator. This study’s findings supported prior research showing that educational
interventions, although efficacious in improving patients’ understanding and knowledge
of glaucoma, do not improve patients’ adherence to follow-up eye exam appointments.
Adherence to Using Prescribed Ocular Medications
Data analysis for evaluating adherence to using prescribed ocular medications at
T3 indicated no statistically significant difference in Group 1 versus Group 2. Marginally,
more participants in Group 2 used their ocular medications (p = .09) compared to
participants in Group 1. Poor adherence to medication regimens accounted for substantial
worsening of the disease and increased health care costs (Feehan et al., 2016).
Researchers have conducted studies to evaluate patients’ adherence to their ocular
pharmacology treatments (Feehan et al., 2016; McVeigh & Vakros, 2015;
Movahedinejad & Adib-Hajbaghery, 2016; Newman-Casey, Robin, et al., 2015; Okeke et
al., 2009). In one of the largest multisite studies, P. F. Cook et al. (2015) reported that
demographic variables, such as age, gender, and occupation, cannot significantly predict
patients’ adherence to glaucoma treatment. Although the inconsistencies between studies
could be due to the populations’ characteristics, as patients age they encounter problems,
such as hand tremors and memory loss, which might negatively affect their ability to use
topical eye medications, thereby decreasing adherence.
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Patient self-reporting was an indirect method of assessing adherence to ocular
medication. Other data came from physicians’ measurement of ocular pressure during the
visit to confirm the pharmacological suitability of the prescribed medication. Sayner et al.
(2015) highlighted particular trends in patients’ compliance. Monnette et al. (2018)
demonstrated that patient adherence with medication improved in the 5 days before and
after the appointment with their physician. According to Newman-Casey, Robin, et al.
(2015), eye drops are far more challenging to self-administer than other medications
because they require physical coordination, manual dexterity, hand-eye coordination, and
good vision, all of which tend to decrease in aging glaucoma patients. Scholars have also
shown that adding a second medication and/or increasing the complexity of glaucoma
therapy is associated with a statistically significant decrease in adherence (Frech et al.,
2018).
I did not evaluate any of the contributing factors to the reasons for ocular
medication noncompliance. However, it is important to note that although the services of
a culturally competent patent navigator assisted patients in retaining glaucoma knowledge
at a 1-month follow-up, there was no statistically significant change in adherence to
medication use according to patient self-report. The study’s findings indicate the
difficulty of improving adherence in an asymptomatic disease that requires lifelong
therapy.
Limitations of the Study
The present study had several limitations. First, there were limitations associated
with using archival data because not directly obtaining information leads to an inability to
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establish authenticity. Second, there is limited generalizability of findings because the
sample did not reflect the general population, instead consisting only of Russian
immigrants residing in New York. A single glaucoma specialty practice provided
participant data, indicating convenience sampling for data collection. Because the patient
navigator was a Russian immigrant, possible positive cultural bias could have been a
limitation if participants wanted to please the patient navigator and put forth more effort
than they would have engaged in otherwise. Finally, multiple barriers unrelated to
adherence might have prevented participants from attending follow-up exams, such as
participant mortality, illness, or inability to get transportation, all of which went
unassessed. Due to cultural differences, the present study’s findings are not generalizable
to other populations.
Archival data presented a significant limitation. Using archival, or secondary, data
means the researcher has not obtained the information directly; therefore, I could not
ensure the results were entirely accurate, limiting the study. Using archived data presents
concerns, including the inability to establish authenticity (Frankfort-Nachmias &
Nachmias, 2008). Authentic research refers to research that is genuine, representing an
actual data set and not a reproduction or copy. Because I did not collect the data directly,
establishing authenticity was not possible.
Additionally, there was a potential for selection bias, which would skew the study
results. Selection bias occurs in the absence of sample randomization, with convenience
sampling leading to uncontrolled population variables (Creswell, 2012). The conveniecne
smaple of 206 participants was randomly split into two groups, Group 1 and Group 2,
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with equal sample size of 103 participants in each. One variable not controlled in the
study was participants who might have been more health conscious and eager to adhere to
the study protocol. Using a convenience sample could also affect the statistical analysis
due to the lack of randomization. Researchers using a nonrandom sample cannot
eliminate systematic bias from the selection procedure or estimate parameters of the data
such that the findings obtained are representative of the overall population (FrankfortNachmias & Nachmias, 2008).
The lack of a standardized patient navigator protocol for the time spent with the
patient limited replicability, as necessary, to ascertain external validity and
generalizability of the findings. Variables such as actual time spent with the patient
navigator, frequency and duration of interappointment phone calls, appointment
reminders, leaving accurate messages, and inability to assess reasons for missing
appointments affected the reliability of the results. Also not controlled for were the
patient navigator’s gender and cultural background, factors that might have influenced
participants’ behavior and answers. Moreover, the patient navigator did not adhere to a
rigid script during patient appointments, likely varying the discussion based on patients’
needs. The patient navigator made a unilateral decision regarding what to address with
each patient, thereby reducing the procedure’s validity and replicability.
The data files were in an encrypted Excel spreadsheet extracted from the
practice’s REDCap database. I manually scanned the spreadsheet for new patients only,
omitting the existing patients’ information. Next, I recorded the data by their corrected
answers, uploading a new Excel spreadsheet into SPSS for data analysis. By using these
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techniques, I was able to minimize limitations and concerns for the study, such as data
contamination from existing patients. The results from this study were consistent with the
findings in the literature, which showed that improved patient knowledge and
understanding of glaucoma is independent of patients’ adherence to follow-up
appointments and use of prescribed ocular medications.
Recommendations
The findings indicated areas for future research, including the study design. My
study population had similar ethnic identification distributions and was isolated to a
localized area in New York. The generalizability of results is low due to the homogeneity
of the population. Studies incorporating broader demographics and diverse ethnic and
racial backgrounds would allow for increased confidence in generalizing results to
populations with similar ethnic identities.
Previous research has shown that providing knowledge and educating patients
about glaucoma did not have a significant effect on improving their adherence to followup care or utilization of ocular medications. Despite prior assumptions that providing and
improving strategies to educate patients about their condition would increase patient
adherence to prescribed treatment, this belief is unsupported. Future studies on improving
ways to engage patients in their own care are necessary. Further research could also focus
on interventions targeting adherence to follow-up care and using ocular medications
independently, without focusing on educational strategies.
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Implications for Social Change
Glaucoma is a chronic, progressive, and asymptomatic disease and is the second
leading cause of preventable blindness worldwide (Newman-Casey, Blanchey, et al.,
2015). Timely, effective, and successful treatment is necessary to reduce intraocular
pressure and minimize glaucoma development and progression (Gupta et al., 2016; Hark
et al., 2017). Achieving these outcomes entails frequent follow-up eye exams and eye
drop administration (Gupta et al., 2016). However, adherence to medical therapies is
notoriously poor, with reported nonadherence rates ranging from 30% to 80% (Prum et
al., 2016). Poor adherence is associated with disease progression and blindness, leading
to significant personal, societal, and economic burdens, such as the loss of health-related
quality of life (Tan et al., 2018; D. D. Zheng et al., 2018). Ongoing visual field loss can
impair patients’ abilities to perform everyday activities through substantially reduced
mobility, more falls and unnecessary trips to the hospital, and negative psychological
effects (D. D. Zheng et al., 2018).
The financial burden of glaucoma rises along with disease severity. Gupta et al.
(2016) found a fourfold increase in direct ophthalmology-related costs as severity
increased from asymptomatic ocular hypertension/earliest glaucoma (Stage 0) through
advanced glaucoma (Stage 3) to end-stage glaucoma/blindness (Stage 5). The average
direct costs per patient per year were $623, $1,915, and $2,511, respectively (Feldman et
al., 2020; Gupta et al., 2016; Varma et al., 2011; Yang et al., 2019). The majority of costs
were medication-related at all severity stages. Individuals with late-stage disease incur
additional indirect costs, placing a substantial burden on health care resources. Late
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disease leads to greater indirect costs, such as family and home help and rehabilitation
costs, which become the predominant driver of overall expense (Feldman et al., 2020).
This study contributed to positive social change. I addressed the literature gap,
investigating a specialized, culturally competent educational intervention provided to
newly diagnosed glaucoma patients to evaluate its effect on improving clinical
management of glaucoma. The positive impact at the individual level could be a
healthier, happier, and more productive person; at the health care delivery level, the
findings could contribute to creating a model of care that is empowered, informed, and
patient-centered; and at the economic level, the findings indicate a need to allocate
resources for more imminent issues affecting the health care of the general population.
This study’s outcomes could form the basis for serious discussions among policymakers.
The study might also enhance the awareness of physicians and the public about the
burden of glaucoma, prioritizing glaucoma care and treatment. Implications for further
scientific investigations include broadly exploring factors affecting nonadherence in
glaucoma patients and ways to improve adherence among the targeted population.
Conclusion
Glaucoma is a growing problem. It is common, often underdiagnosed, costly,
distressing to patients and families, and disabling. As glaucoma prevalence increases
exponentially with age, its incidence is rising among the rapidly aging population
(Fenwick et al., 2020). Economic and individual costs increase with disease severity;
however, proactive glaucoma management can reduce the overall disease burden. Early
identification and treatment of patients with glaucoma and those with ocular hypertension
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at high risk of developing vision loss can reduce the individual burden of disease on
health-related quality of life and minimize personal and societal economic burdens.
This study showed that an in-person, individualized educational session provided
by a culturally competent patient navigator was effective in improving patients’
knowledge and understanding about the disease well into their 1-month follow-up
appointment. However, this knowledge was independent of the patients’ adherence to
attending a follow-up appointment or using their ocular drops. This study showed that
each patient is likely to have a unique set of issues to address to optimize adherence. It is
possible that the greater the number of barriers identified, the greater the likelihood of
nonadherence (see Newman-Casey, Robin, et al., 2015). It was possible to predict
nonadherent behavior according to the TTM, or the stages of change, indicating
individuals’ enormous capacity to change harmful or undesirable behavior (DiClemente
& Prochaska, 1982, 1998; Prochaska & Vellcer, 1997). Interventions focused on
improving adherence should build self-efficacy, teach patients proper eye drop
instillation, and address forgetfulness and difficulties with the medication schedule
(Feehan et al., 2016). Providers should individualize interventions, tailoring information
and approaches to address each patient’s unique set of barriers. All health care providers
should pay attention to their patients’ predictive adherent behaviors to identify the best
corrective measures to achieve optimal treatment.
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